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Reproducibility between analysts. Five data sets, each at 
a different sonomicrometry setting, were recorded. Each 
of two analysts processed a single heartbeat (not neces- 
sarily the same heartbeat) from each of the five data sets, 
and all intertransducer distances were determined at 
end-diastole by means of MDS. This produced five pairs 
of heartbeats, one from each analyst at each sonomi- 
crometer setting, which were compared as follows. The 
two measurements of the 120 end-diastolic chord lengths 
were averaged (n = 2) and the absolute difference for 
each of the 120 chord lengths was determined. The 
normalized error for each chord length was estimated by 
dividing the absolute difference by the mean of the two 
measurements, and the mean of these 120 normalized 
errors was found. Each pair of heartbeats was also com- 
pared by use of the Procrustes algorithm. The mean, 
standard eviation, and range of five normalized istance 
errors and the mean of five Procrustes absolute errors 
were calculated. 
Combined reproducibility. An estimate of the effect of 
total potential variability on the reproducibility of the 
technique was performed. Five data sets, at a single 
sonomicrometer setting, were collected. The sonomi- 
crometer settings were changed, and another five data sets 
were recorded. One heartbeat from each of the first five 
data sets was reduced by one analyst; the second analyst 
processed one heartbeat from each of the second five data 
sets. Each data set processed by analyst 1 was compared 
with each data set processed by analyst 2, for a total of 25 
comparisons. For each comparison, a mean normalized 
chord length error was calculated and a Procrustes rota- 
tion was performed. 
Reproducibility between study sessions. Data were col- 
lected from the same sheep during two study sessions 24 
hours apart. The hemodynamic conditions on both days 
were similar. The sonomicrometer settings and analyst 
were the same for both sessions. The two data sets were 
compared by calculating the average difference and aver- 
age percent difference of all 120 chord lengths, as well as 
applying the Procrustes algorithm to assess the differences 
in crystal coordinates between data sets. 
Appendix 2 
The Procrustes rotation is a least-squares method used 
to superimpose and compare two multidimensional con- 
figurations. Let X be an n × p matrix of the coordinates of 
n points obtained by one measurement method. Let Y be 
another n × p matrix of the coordinates of those same n 
points obtained by a different measurement method. The 
residual sum of squares of Y relative to X is: 
n 
~l(xr -y r )  l z (3) 
r= l  
where x r and Yr are the individual points of X and Y 
respectively. The residual sum of squares can be mini- 
mized by rotating or translating Y relative to X as 
follows: 
Ar 'y r -b , r= l , . . . ,n  (4) 
where A' is the transpose of a p × p orthogonal matrix. If 
equations i and 2 are combined in the following equation: 
i1 
R 2 = ~ ](xr - Ar'Yr - b)] 2 (1) 
r - -1  
and values of A' and b are obtained such that R 2 is 
minimized, then Y is superimposed on X. Values of A' and 
b are obtained in the following manner. Let 
Z = Y'X (5) 
where Y' is the transpose of Y. By singular value decom- 
position: 
Z = VFU' (6) 
where V and U are orthogonal (p × p) matrices, U' is the 
transpose of U, and F is a diagonal matrix of nonnegative 
elements. The minimizing solution for equation 3 is given 
by: 
b=0,  A=VU ' (7) 
and further: 
R 2 = trXX' + trYY' - 2trF (8) 
where tr is the trace of a matrix, X' is the transpose of X, 
and Y' is the transpose of Y. 
Commentary 
Gorman and associates present an elegant study pro- 
viding information important to the physiology of mitral 
valve function and of mitral valve repair and replacement. 
This study, like that of Komeda and associates, 1 docu- 
ments the precise spatial relationships of various parts of 
the mitral valve relative to the left ventricle and to the 
chest wall throughout he cardiac cycle. Although the 
study examined anesthetized, normal sheep, their data 
have several implications for human beings with mitral 
valve disease: 
1. The saddle shape of the normal mitral valve through- 
out the cardiac cycle is confirmed. The importance of 
maintaining this shape during mitral valve operations 
remains highly debated. 
2. Systolic torsion of the left ventricle is confirmed, as 
demonstrated by others using magnetic resonance and 
tantalum radiography. The effects of mitral valve surgery 
on left ventricular torsion and the significance of these 
effects are only now being assessed. 
3. Gorman and associates a clearly show that the papil- 
lary muscles rotate relative to the mitral valve anulus 
during the cardiac cycle, and this rotation is greatest for 
the posterior papillary muscle. This finding suggests that, 
as viewed from the left atrium, surgically placed artificial 
chordae or transposed chordae would most optimally be 
oriented in a counterclockwise direction relative to the 
anulus to maintain ormal eft ventricular torsion. While 
chordal placement during mitral valve repair is more 
directed by reconstructing ormal anatomic relationships, 
placement of artificial chordae during mitral valve re- 
placement when the native chordae are absent 2 is entirely 
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at the discretion of the surgeon, who would be wise to 
heed the findings of Gorman, and Komeda, and their 
colleagues. 1 
4. Gorman and coworkers graphically demonstrate s v- 
eral geometric aspects of normal mitral function that may 
be of relevance to the pathophysiology and repair of 
ischemic mitral regurgitation. These include papillary 
muscle shortening, mitral valve descent toward the apex in 
systole, rotation of the posterior papillary muscle relative 
to the anulus, and narrowing of the ventricular cavity. The 
relative roles of these factors in ischemic mitral regurgi- 
tation are yet to be demonstrated. 
As Gorman and associates uggest, the technique of 
sonomicrometry array localization (SAL) has merit as a 
relatively inexpensive laboratory technique to precisely 
assess cardiac geometry after mitral valve operation, after 
myocardial infarction, and in the presence of mitral valve 
disease. Like any good study, this work demonstrates 
many areas in which further work is needed to fill gaps in 
our current knowledge. Future studies using the tech- 
niques of Gorman and colleagues may suggest refine- 
ments of mitral valve repair and replacement techniques 
that will improve the applicability of mitral valve repair 
and improve the functional results of mitral valve opera- 
tions. 
Donald D. Glower 
Associate Professor of Surgery 
Duke University Medical Center 
Durham, NC 27710 
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The costs of heart operations and the problems related to anticoagulation after 
prosthetic valve replacement are among the limitations faced by patients in 
nonindustrialized countries with mitral stenosis caused by chronic rheumatic 
heart disease. The young age at which these patients are seen also compels the 
surgeon to preserve the native valve. The least costly and optimal way to 
achieve this objective is by closed mitral valvotomy. After closed mitral 
valvotomy, mitral restenosis is commonly encountered. We report here our 
10-year experience with operation on 113 consecutive patients with mitral 
restenosis. Closed transventricular evalvotomy was performed with Tubbs 
dilator in 105 of 113 patients. Mean age was 34.3 years, with a male to female 
ratio of 1:1.5. Most patients were in New York Heart Association functional 
classes III and IV (74.3% and 19.4%, respectively). Mean interval between first 
and second valvotomy was 9.4 years. Hospital mortality rate was 2.8%, trivial 
postoperative mitral regurgitation occurred in 16.1%, and moderately severe 
regurgitation occurred in 1.9%. Early postoperative systemic embolism oc- 
curred in 3.8% of the cases. Moderate to excellent symptomatic improvement 
was noted in 89.4% of the cases and poor results were seen in 10.2%. Late 
follow-up of 76 patients ranged from 2 to 10 years (mean 3.8 years), with 
39.4% patients in New York Heart Association class I and 50% in class II. 
Close mitral revalvotomy is thus an economical, simple, and safe palliative 
procedure that carries good long-term results. (J Thorac Cardiovasc Surg 
1996;112:727-30) 
W ith the introduction of cardiopulmonary by- pass, the technique of closed transventricular 
mitral valvotomy (CMV) for mitral stenosis was 
virtually abandoned in industrialized countries. This 
technique continues to be used in most centers in 
nonindustrialized countries, however, because of its 
cost-effectiveness and to avoid the problem of anti- 
coagulation therapy after prosthetic mitral valve 
replacement (MVR). Restenosis i a known compli- 
cation after CMV, and its prevalence has been 
reported to range widely, varying between 2% and 
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60%. 1-3 Approximately 10% of patients returning to 
the hospital with persistent or recurrent symptoms 6 
years after operation have true restenosis, 4 Virtually 
no differences have b en reported with respect o 
the short-term results achieved with the three 
available palliative procedures: CMV, open mitral 
valvotomy or commissurotomy (OMV), and balloon 
mitral valvotomy (BMV). s It will take more time, 
however, for evaluation of long-term results of 
OMV and BMV. 
Considering the relatively ounger age at which our 
patients are seen and their socioeconomic status, our 
effort has been to adopt a palliative procedure with a 
low cost and without problems of anticoagulation, 
while at the same time preserving the native valve. In 
this retrospective study, we analyzed the results of 
CMV in 105 of total 113 consecutive patients with 
mitral restenosis at the Post Graduate Institute of 
Medical Education and Research, Chandigarh, India. 
Patients and methods 
This study comprises 113 consecutive patients with 
mitral restenosis who underwent reoperation during a 
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Table I. Patient age at CMR (n = 113) 
Age group 
(yr) No. % 
13-25 13 11.5 
26-40 71 62.8 
41-50 24 21.2 
>50 05 4.4 
TOTAL 113 - -  
Table II. Preoperative chocardiographic f ndings 
(n = 113) 
Pathology No. % 
Calcification 43 38.0 
Mild 24 21.2 
Moderate 13 11.5 
Severe 6 5.3 
Subvalvular pathology 78 68.9 
Mild 46 40.7 
Moderate 28 24.7 
Severe 4 3.5 
Left atrial clot 2 1.7 
Mean valve area 0.74 cm 2. 
10-year period (January 1982 to December 1992). These 
patients were evaluated clinically and echocardiographi- 
cally. Most were found to be suitable candidates for closed 
mitral revalvotomy (CMR). Six patients with heavily cal- 
cified valves underwent MVR, and two patients in whom 
a left atrial clot was detected on echocardiography under- 
went OMV. In the remaining 105 patients, CMR was 
carried out. One hundred two of these patients underwent 
CMR for the first time and three patients had successful 
second CMRs. Patients who had symptoms within 3 years 
of the first CMV were excluded from this study because 
they were considered to have an inadequate initial valvo- 
tomy. 
Of 113 patients with mitral restenosis, 45 were male and 
68 were female (1:1.5). Their ages ranged from 14 to 56 
years, with a mean of 34.3 years (Table I). Most of the 
patients were in New York Heart Association functional 
classes lII (74.3%) and IV (19.4%). Hemoptysis was 
present in 15.9% of the patients, and atrial fibrillation was 
present in 55% of the patients. Preoperative systemic 
embolic episodes occurred in 11 patients (10%), with 
detectable ft atrial clot in only two. The mean interval 
between first CMV and CMR was 9.4 years; that between 
first CMV and MVR was 6.2 years. Preoperative echocar- 
diographic findings are listed in Table II. Mean mitral 
valve area according to echocardiography was 0.74 cm 2. 
A left anterolateral thoracotomy approach was used for 
all patients. Through the previous incision scar, the chest 
was entered through the bed of the fifth rib. Adhesions 
were separated by sharp dissection to expose the body of 
the left atrium, adjacent left superior pulmonary vein, and 
left ventricular apex. Double purse-string sutures of 2-0 
Prolene (Ethicon, Inc., Somerville, N.J.) or silk were 
placed over the body of left atrium, extending onto the 
Table III. Operative complication of CMR (105 
cases) 
Complication No. % 
Mitral regurgitation 19 18.0 
TrMal 17 16.1 
Severe 2 1.9 
Systemic embolism 4 3.8 
Intraoperative hypotension 12 11.4 
Intraoperative ventricular 3 2.8 
fibrillation 
Failure to dilate valve 1 0.9 
entry of left superior pulmonary vein, for introduction of 
the surgeon's right index finger. Another mattress suture 
with 2-0 silk was placed at the left ventricular apex 
adjacent to the previous ventriculotomy site for introduc- 
tion of a Tubbs dilator. The orifice of the mitral valve was 
dilated to 3.25 or 3.5 cm in diameter. 
A total of 76 patients who had undergone CMR were 
evaluated clinically and with echocardiography. Evalua- 
tion was performed 2 to 10 years (mean 3.8 years) after 
operation. 
Results 
A complete and satisfactory commissurotomy was 
achieved in 95 of the 105 patients who underwent 
CMR. In one case, the procedure had to be aban- 
doned because the Tubbs dilator could not be 
negotiated across the mitral valve orifice as a result 
of severe subvalvular pathology. Postcommissur- 
otomy mitral regurgitation occurred in 19 patients. 
Regurgitation was trivial in 17 patients (16.1%) and 
moderately severe in two patients (1.9%). Of the 
two patients with moderately severe mitral regurgi- 
tation, one underwent emergency MVR and the 
other died before operation of acute intractable 
pulmonary edema and low cardiac output. Postop- 
erative systemic embolism occurred in four patients 
(3.8%). Intraoperative ventricular fibrillation that 
could be successfully converted with direct current 
shock occurred in three patients. Operative compli- 
cations are listed in Table III. Early in-hospital 
death (defined as death occurring within 30 days 
after operation) after CMR was 2.8%. There were 
no operative complications in the three patients who 
underwent a second CMR. Causes of death after 
CMR for mitral restenosis are shown in Table IV. 
Ecfiocardiography from 84 patients at first fol- 
low-up (1 to 3 months) showed adequate valvotomy 
(mitral valve area ->1.75 cruZ) in 88.1% and inade- 
quate valvotomy (mitral valve area <1.75 cruZ) in 
11.9%. Mean mitral valve area was 1.82 cruZ. The 
functional statuses of 76 patients at 2- to 10-year 
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Table IV. Cause of  death after CMR (n = 105) 
Cause No. 
Cerebral embolism 1 
Low cardiac output with mitral 1 
regurgitation 
Ventricular arrhythmia 1 
Total deaths 3 
follow-up (mean 3.8 years) are shown in Table V. 
The occurrences of restenosis were 8.4 at 5 years 
and 20.2 at 10 years per 1000 patients per year after 
CMR. None of our patients had any evidence of 
recurrence of acute rheumatic activity. There was no 
subsequent increase in mitral regurgitation among 
patients in whom trivial mitral regurgitation periop- 
erative had developed. 
Discussion 
CMV is an established surgical procedure for 
treatment of mitral restenosis, however, only a few 
studies assessing its results have been reported. 1'6, 7 
The current consensus in industrialized countries 
favors open operative techniques. 2' 8 Despite many 
reports on the effectiveness of OMV, it is not certain 
whether the results are sufficiently superior to those 
of CMV to justify the higher cost involved in an 
open procedure, an important factor particularly in 
nonindustrialized countries. 9 Farhat and associ- 
ates 1° reported a mean mitral valve area of 2.1 cm 2 
after OMV for noncalcific mitral stenosis. In earlier 
reports, survival after CMV was rather disappoint- 
ing.~l, 12 Recent studies, however, have shown low 
early and late mortality rates after CMV both for 
primary mitral stenosis and restenosis. 1' 6, 13 MVR 
carries the risk of thromboembolism, echanical 
failure, prosthetic valve endocarditis, and problems 
related to anticoagulation. The incidences of mitral 
regurgitation after CMV and OMV are similar. The 
reported incidence of MVR after OMV in a fol- 
low-up of 4.4 years to 8.6 years is 7% to 18%. 2, 14 
Younger surgeons have shown a preference for 
MVR.lS, 16 
Although BMV has recently gained populari- 
ty, lO, 17-20 its cost and short-term palliative results 
compared with those achieved by CMV are limiting 
factors. 21 In the available literature, there are no 
reports defining the role of percutaneous BMV for 
mitral restenosis. 22The results of surgical commis- 
surotomy (OMV, CMV) and BMV are simi- 
lar,~4, 23, 24 and only the patient's preference and the 
cost factor guide the choice of the procedure to be 
Table V. Functional status at late follow-up (2 to 
lO yr, mean 3.8 yr; n = 76) 
Preoperative Postoperative 
NYHA Functional 
Class No. % No. % 
I 0 0 30 39.4 
II 4 5.2 38 50 
III 62 81.5 6 7.6 
IV 10 13.1 2 2.6 
NYHA, New York Heart Association. 
performed. In an editorial, Frater 5 cautioned that 
the results achieved by BMV are as good as those of 
CMV, provided that complications (including resid- 
ual atrial septal defect, cardiac perforation, and 
iatrogenic mitral regurgitation) are not in excess of 
those associated with operation. It has been pre- 
dicted that in appropriately selected patients the 
long-term clinical outcome after BMV may be ex- 
pected to be similar to the available data for surgical 
commissurotomy (OMV, CMV)Y 
Restenosis is the result not only of inadequate 
valvotomy but also of a continuing fibrotic process. 1 
Progressive restenosis correlates not only with time 
but also with the pathologic state of valve at surgical 
intervention. 5 The relatively younger age of our 
patients, a mean of 34.3 years, forced us to evolve a 
strategy to conserve the native valve through CMV 
or CMR. Any other procedure would have led to 
increased costs and lesser acceptability of a valvular 
prosthesis in our social milieu. Logically, the basic 
social circumstances and inadequate health care 
facilities available for our population group at risk, 
compels us to adopt the most cost-effective proce- 
dures in our country. The results have been so 
gratifying in our patients that we believe every effort 
should be made to preserve the native valve until a 
more acceptable valve substitute is available. 
MVR caries the hazards of anticoagulation, with 
the necessity of life-long expenditure and strict 
treatment compliance. Because most of our popu- 
lation at risk has a rural background and poor 
socioeconomic status, compliance with an anticoag- 
ulation schedule is always doubtful in our country, 
and noncompliance often leads to serious post- 
MVR complications. 
In our experience, the early operative mortality 
rate is less than that reported for earlier series, 6' 13 is 
easily comparable with that of OMV, 8' 26, 27 and is 
certainly less than that for MVR. 28 Mitral regurgi- 
tation carries an important prognostic significance 
for functional outcome necessitating MVR 19' 2o but 
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was trivial in most of our cases (16.1%). There is no 
reported difference in the prevalences of mitral 
regurgitation associated with the three palliative 
procedures available for the treatment of mitral 
stenosis. 25 The l imitation common to CMV, BMV, 
and OMV is calcified valve; that common to both 
CMV and BMV is left atrial clot. 
Conclusion 
New York Heart  Association functional class 
improved in most of our patients after CMR. In our 
opinion, CMV for mitral restenosis still offers excel- 
lent pall iation with low r isk,  low cost, and good 
long-term results in most patients, without the haz- 
ards of anticoagulation. 
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The in situ right internal thoracic artery graft brought through the 
transverse sinus was used to revascularize the posterolateral wall in 116 
patients. Its advantages were assessed retrospectively. The graft was 
anastomosed to the circumflex marginal branch in 70 patients (60%) or to 
the posterolateral branch in 41 patients (35%). One patient died (mortality 
rate 0.9%). Perioperative myocardial infarction occurred outside the terri- 
tory of the right internal thoracic artery graft in 10 patients, four of whom 
required mechanical support for hemodynamic deterioration. Postopera- 
tive early angiography in 114 patients found the graft to be patent in 97.4%. 
The ratio of the diameter of the right internal thoracic artery to that of the 
recipient marginal branch was 0.94 - 0.18 (n = 69), and that to the 
posterolateral branch was 0.88 - 0.18 (n = 37) (not significantly different). 
Results of a postoperative stress test were abnormal in one patient (1/96 
tested patients). This retrospective study suggests that the right internal 
thoracic artery brought through the transverse sinus to revascularize the 
posterolateral wall provided excellent early patency and good clinical 
results, even to the most distally located branches. This continues to be our 
procedure of choice for patients with multivessel coronary disease. 
(J Thorac Cardiovasc Surg 1996;112:731-6) 
T he long-term patency rate of internal thoracic artery (ITA) grafts has been far superior to that 
of saphenous vein grafts. 1-5 At present he ITA is 
considered the conduit of first choice for coronary 
artery bypass grafting (CABG), and double ITA 
grafts were expected to improve survival. 6-12 How- 
ever, on long-term follow-up only better clinical 
benefits were noted. The study, however, included a 
high early mortality. 13 In an effort to further expand 
the use of arterial grafts, free ITA grafts 14-a6 or 
sequential ITA grafts 14' 17, 18 have been advocated. 
The need for an aortic anastomosis in free grafts 
necessarily adds a potential site of occlusion, as 
reflected by the 77% patency rate reported by the 
Cleveland Clinic groupJ  6 In our institution, when 
both ITA grafts are used for coronary revasculariza- 
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tion the right ITA is brought hrough the transverse 
sinus for grafting the circumflex area, as described 
by Puig and associates 19and the left ITA is anasto- 
mosed to the left anterior descending (LAD) coro- 
nary artery. Bringing the right ITA through the 
transverse sinus for grafting has been controversial 
ever since its original description by Puig's group. 
To further evaluate the method, we analyzed retro- 
spectively the early postoperative angiograms, the 
stress tests, and the morbidity and mortality. 
Patients and methods 
Patient population. In 23% (116 patients) of all pa- 
tients undergoing isolated CABG from September 1989 to 
December 1994, we used the in situ right ITA via the 
transverse sinus for revascularization f the posterolateral 
wall of the left ventricle. The preoperative characteristics 
of the patients are shown in Table I. Hypertension was 
defined as a diastolic pressure greater than 90 mm Hg or 
as the need for antihypertensive m dication. Diabetes was 
considered present if patients were receiving insulin or 
oral hypoglycemic agents or had been placed on calorie- 
restricted iets by a physician. Hyperlipidemia was con- 
sidered present in patients whose serum cholesterol level 
was greater than 260 mg/dl, or whose serum triglyceride 
level was greater than 200 mg/dl, or who were being 
treated with oral medication. Left main trunk disease was 
defined as greater than 50% stenosis of the left main 
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Table I. Clinical profile 
Mean age (yr) 62.6 (13-77) 
Male/female 95:21 
No. of vessels diseased 
Left main trunk 38 (33%) 
One vessel 0 
Two vessels 24 (21%) 
Three vessels (without left main trunk) 54 (47%) 
Risk factors 
Hypertension 60 (52%) 
Diabetes mellitus 28 (24%) 
Hyperlipidemia 39 (34%) 
Previous myocardial infarction 68 (59%) 
Previous cerebral vascular accident 8 (7%) 
Table I I .  Operative data 
Mean No. of distal anastomoses 3.4 _+ 0.9 
Mean No. of arterial graft anastomoses 2.1 ± 0.4 
ECC time (min) 144 _+ 38 
Asc. Ao clamp time (min) 94 _+ 29 
RITA + vein 3 
RITA + LITA 20 
RITA + LITA + vein 90 
RITA + LITA + RGEA 1 
RITA + LITA + RGEA + vein 2 
ECC, Extracorporeal circulation; Asc Ao, ascending aorta; RITA, right 
internal thoracic artery; LITA, left internal thoracic artery; RGEA, right 
gastroepiploic artery. 
trunk. Fourteen of those had branch vessel disease as well. 
Two patients had sequelae of cerebrovascular disease, one 
having left hemiplegia nd the other right hemiplegia. 
Operative data. The combinations of graft conduits 
and other operative data are illustrated in Table II. Both 
ITAs were harvested in all patients; the left ITA could not 
be used in two because of injury at he time of harvesting, 
and in another patient the left ITA was lacerated after the 
patient had been weaned from cardiopulmonary b pass, 
and the arterial graft had to be replaced with a venous 
graft. Therefore 113 patients (97%) ultimately had bilat- 
eral ITA grafts. In addition to bilateral ITA grafting, three 
patients received a right gastroepiploic artery graft. Over- 
all, revascularization was accomplished with only arterial 
grafts in 21 patients. 
The target vessels for the left ITA and right ITA grafts 
are shown in Table III. The left ITA was anastomosed to
the LAD system in 109 cases (96%). Sequential ITA 
grafting was used for the diagonal branch-LAD combina- 
tion in 11 patients; two left ITA conduits were used as free 
grafts. The right ITA via the transverse sinus was grafted 
to the marginal branch in 70 patients (60%) and to the 
posterolateral branch in 41 patients (35%). No right 
coronary artery branch was revascularized with the ITA. 
Operative technique. Both ITAs were harvested with 
the use of low-current electrocoagulation a d metallic 
clips (Ethicon, Inc., Somerville, N.J.), with both pleural 
cavities being opened. The ITA pedicle was mobilized 
with 2 cm wide margins from the point 2 cm distal to its 
bifurcation into the superficial epigastric and musculo- 
Table I I I .  Target vessels of ITA grafts 
No. of gral~s 
RITA grafts via transverse sinus 
Circumflex system 
Marginal branch 70 
Posterolateral branch 41 
Diagonal branch 5 
Total 116 
LITA grafts 
LAD 96 (free graft, 2) 
Diagonal branch 2 
Diagonal branch-LAD (sequential) 11 
Circumflex artery 4 
Total 113 
RITA, Right internal thoracic artery; LITA, left internal thoracic artery; 
LAD, left anterior descending coronary artery. 
phrenic branches to its origin. A Jostra retractor (Jostra 
Medizintechnik GmbH & Co. KG, Hirrlingen, Germany) 
was used routinely to facilitate this procedure. After 
systemic heparinization, the distal branches were clipped 
and divided and the pedicle was wrapped with papaverine- 
soaked gauze (200 mg/50 ml of saline solution). Hemo- 
stasis of both ITA pedicles was completed before cardio- 
pulmonary bypass was established, all branches being 
dipped or ligated whether actively bleeding or not. An- 
teroposterior incisions of the pericardium toward both 
phrenic nerves at the pleuropericardial reflection were 
made to provide the shortest route from the ITA origins 
to the recipient coronary artery while the patient was 
being cooled (Fig. 1). Just before the ascending aorta was 
crossclamped, the right ITA pedicle was pulled through 
the transverse sinus to reconfirm adequacy in length. 
Myocardial protection was achieved with antegrade cold 
crystalloid cardioplegia for the first dose, supplemented 
with topical cooling (cold saline solution) and systemic 
hypothermia (rectal temperature 32 ° C). For the second 
and subsequent doses, intermittent (every 30 minutes) 
cold potassium-magnesium blood cardioplegic solution 
was used. The ITA-coronary artery anastomosis was 
performed with continuous 7-0 polypropylene suture 
(Prolene; Ethicon) with optical magnification. Hemostasis 
not only of the anastomosis but also of the pedicle was 
carefully checked. When conduits necessitating aortic 
anastomoses were us d, both proximal and distal anasto- 
moses were performed uring a single period of aortic 
crossclamping rather than using a side-biting clamp. After 
resumption of spontaneous beating and when the mean 
arterial pressure reached 60 to 80 mm Hg, hemostasis of 
the right ITA pedicle placed via the transverse sinus was 
checked for the last time before the patient was weaned 
from cardiopulmonary b pass. 
Postoperative angiography and stress test. Early post- 
operative angiography was done 2 to 3 weeks after the 
operation. The diameters of the native recipient coronary 
arteries, as well as of the ITAs, were measured in at least 
two views for determination of the diameter atios to 
evaluate size matching. The modified Sheffield test or the 
Bruce exercise test was also performed before or after the 
angiograms. 
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Fig. 1. Right-sided pericardium was incised along the dotted line and right ITA graft (IMA) was pulled 
through the transverse sinus to graft the target vessel. SVC, Superior vena cava; RA, right atrium; asc. Ao, 
ascending aorta; PA, pulmonary artery. 
Statistical methods. Data were analyzed by means of 
the StatView II statistical software package (Abacus Con- 
cepts, Inc., Berkeley, Calif.). The )(2 test was used to 
determine significance for discrete variables and Yates' 
correction for continuity was applied where applicable. 
Continuous variables were analyzed by means of Student's 
t test. Values were expressed as the mean _+ the standard 
deviation unless otherwise specified. A p value of < 0.05 
was considered significant. 
Results 
Mortality. No patient died within 30 days after 
the operation. The only hospital mortality (>30 
days) (0.9%) occurred in a 69-year-old-woman with 
a history of bronchial asthma who underwent quad- 
ruple CABG (both ITA grafts and two saphenous 
vein grafts) who required ventilator support for 5 
days. On postoperative day 49 administration of 
local anesthetic (1% lidocaine) to repair the left leg 
wound was followed by a severe asthmatic episode 
again necessitating ventilator support, which was 
complicated by pneumonia. She died of septic shock 
on postoperative day 61. 
Morbidity. Hospital complications are shown in 
Table IV. Perioperative myocardial infarction, de- 
fined as enzyme elevation (creatine kinase MB 
isozyme concentration >100 units) or the appear- 
ance of new Q waves on the electrocardiogram (or
both) occurred in 10 patients, four requiring me- 
chanical support (intraaortic balloon pumping): 
Two needed intraaortic balloon pumping immedi- 
Table IV. Hospital complications 
No. % 
Perioperative myocardial infarction 10 8.6 
Mechanical support (IABP) 4 3.4 
Respiratory insufficiency 5 4.3 
Reoperation for bleeding 3 2.6 
Stroke 2 1.7 
Sternal wound complications 19 16 
Superficial wound infection 4 
Skin layer dehiscence 14 
Sternal fracture from wire cutting 1 
Bacteriologic mediastinitis 3 2.6 
IABP, Intraaortic balloon pump. 
ately after cardiopulmonary b pass for ventricular 
arrhythmia caused by anterior wall ischemia; in the 
other two patients an inferior wall myocardial in- 
farction developed 10 hours after the operation. No 
myocardial infarctions were observed after 24 hours, 
and none of the perioperative myocardial infarc- 
tions were in the territory of the right ITA. Respi- 
ratory insufficiency, defined as ventilator depen- 
dency for more than 48 hours, occurred in five 
patients. In none was it related to phrenic nerve 
palsy. Pulmonary embolism occurred in one patient, 
and one patient with asthma died late, as men- 
tioned. Reexploration for bleeding was necessary in
the other three patients, but bleeding points were 
not related to ITA anastomoses or pedicles. Post- 
operative stroke was recognized in two patients: 
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Table V. Early postoperative angiographic 
assessment about right ITA grafting 
Result 
Recipient coronary artery 
Marginal Posterolateral Diagonal 
artery artery branch 
Good patent 68 38 5 
Slow flow 1 1 - -  
Graft occlusion - -  1 - -  
98.6% 95.0% 100% 
Patency rate / J 
97.4% 
ITA, Internal thoracic artery. 
One who awoke with disorientation a d monoplegia 
of the right leg had evidence of a small cerebral 
infarction in the left basal ganglion, but he was 
discharged without any sequelae. The other was 
delirious, complained of hemianopsia, nd had evi- 
dence of occipital obe infarction, but his mental 
state was clear at discharge. Sternal wound prob- 
lems were observed in 22 patients: Fourteen had 
skin layer dehiscence but no growth of organisms on 
culture, four had superficial infections (Staphylococ- 
cus epidermidis), and one had a sternal fracture 
caused by the sternal wire cutting, but negative 
cultures. Sixteen of them required only local wound 
care, one patient needed rewiring, and the other two 
patients healed spontaneously. Mediastinitis (with 
positive cultures) occurred in three patients, two of 
whom had diabetes. Two were treated with ddbride- 
ment, open irrigation, and antibiotics, and the other 
patient was treated with an omental f ap. Ten of the 
22 patients with wound problems (45%) had diabe- 
tes. In these 22 patients the mean hospitalization 
period was lengthened by 8 days. 
Postoperative angiography. Early postoperative 
angiography was performed in 114 patients (98%) 
(Table V). Only ITAs with a smooth transition from 
the graft to the recipient coronary artery without 
evidence of any stenosis were defined as patent in 
this series. If the arteriographic flow velocity was 
poor, even if there was no evidence of stenosis or 
occlusion, the flow was termed "slow flow" and the 
graft was not regarded as patent. There was no 
statistically significant difference among the three 
groups categorized by anastomotic sites, the overall 
patency rate of the right ITA graft being 97.4%. The 
diameter ratios of ITA and recipient coronary artery 
at the anastomotic site on the postoperative anglo- 
gram (as measured with calipers on the screen) were 
compared between the 69 patients with grafts to the 
marginal branch and the 37 patients with grafts to 
the posterolateral branch, and the difference was 
not statistically significant (0.94 ___ 0.18 vs 0.88 +_ 
0.18). 
Stress test. A postoperative exercise test was 
performed in 96 patients (83%), and the results 
were abnormal in only one patient (1%), who was 
free of symptoms. This patient had three vessels 
bypassed (left ITA to LAD, right ITA to circumflex, 
vein graft to right coronary artery), and all grafts 
were angiographically patent. The distal circumflex 
artery had three branches, every one with 90% 
stenosis. The right ITA had been grafted to the 
largest branch, and it is possible that the two other 
ungrafted branches were the cause for the abnor- 
mal results of the stress test. Except in the patient 
with the abnormal test results, the average attained 
maximal exercise was 4.6 _+ 1.4 metabolic equiva- 
lents. 
Discussion 
The superiority of ITA grafts over venous con- 
duits has been documented. 1-5' 2o, 21 Patients receiv- 
ing a left ITA graft to the anterior wall had im- 
proved long-term survival and a reduction in the 
rate of reoperation and late cardiac events as com- 
pared with patients revascularized with saphenous 
vein. In an effort to expand the use of this superior 
conduit, different types of ITA grafts were adopted, 
such as bilateral ITA grafts, sequential bypasses, and 
free grafts. A number of institutions have reported 
on the usefulness of bilateral ITA grafts. 6-13 We 
have used this method rather aggressively since 
1990. Bilateral ITAs are harvested almost routinely 
if angiograms uggest hat the locations of the 
coronary lesions are amenable to in situ bilateral 
ITA grafts and no obvious contraindications exist. 
Our 97% patency rate of in situ right ITA grafts, 
even though early, compares favorably with the 77% 
rate for free ITA grafting at 18 months reported by 
Loop and associates. 16 We believe that if the ITAs 
can be used in situ, the results are better than when 
they are used as free grafts. Our current contrain- 
dications for bilateral ITA grafting include the fol- 
lowing: patients older than 75 years, female patients 
in poor physical condition, patients with chronic 
obstructive pulmonary disease, patients with arterio- 
sclerosis obliterans distal to the iliac artery, and 
patients with severe diabetes. 
The target vessels for ITA anastomoses differ 
according to the policy of each institution. When we 
use bilateral ITA grafting for CABG, the anastomo- 
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sis pattern left ITA to LAD and right ITA to 
circumflex, as described, is generally followed. This 
strategy is based on two considerations: (1) no 
necessity to cross the midline anterior to the aorta, 
thus avoiding risks in case reoperation is required; 
(2) size matching, that is, the left ITA graft reaches 
the generally largest coronary artery, the LAD, at a 
level where is still of good caliber, and the right ITA 
brought through the transverse sinus matches the 
circumflex branches. 
However, because of the risks of overstretching or
rotating the right ITA and the difficulties in manag- 
ing pedicle bleeding, some reports discredited the 
original advantages. Rankin and associates 14have 
reported occlusion in two of 20 patients and slow 
flow in three others. In the report by Ramstorm and 
colleagues, 22the right ITA through the transverse 
sinus could reach only the most proximal parts of 
the circumflex artery; consequently the right ITA 
was predominantly used to revascularize the LAD. 
In our series the early postoperative patency of the 
right ITA to circumflex branches was 97.2%, and in 
only one of 109 cases was it found to be totally 
occluded. None of our patients required reexplora- 
tion for pedicle bleeding. 
This method of bringing the right ITA via the 
transverse sinus is indeed more demanding techni- 
cally; however, the most important aspect is perhaps 
careful assessment of length before anastomosis and 
obtaining adequate hemostasis of the pedicle before 
passing it through the transverse sinus. In our 
experience we have never changed the target vessel 
because of length inadequacy, and we have had to 
use the right ITA as a free graft in only two patients. 
The ITA pedicle is inspected at least three times for 
adequate hemostasis. All branches, whether actively 
bleeding or not, are clipped or ligated. 
Thirty-five percent of our right ITA grafts were 
anastomosed to the distal posterolateral branch. 
The following are the key points to keep in mind: (1) 
For maximum length, the pedicle should be har- 
vested after the pleura has been opened; (2) the 
shortest route to the coronary artery is gained by 
incising anteroposteriorly the right-sided pericar- 
dium anterior to the phrenic nerve at the level of the 
transverse sinus and then curving the incision crani- 
ally alongside the superior vena cava; (3) the distal 
ITA beyond its bifurcation may have to be used for 
anastomosis to distal circumflex branches. Although 
we have not measured flows directly during the 
operations, the good size matching of the ITA graft 
to the coronary artery and the normal postoperative 
exercise test results seem to substantiate the flow 
adequacy and validity of these points. The postopera- 
tive stress test result was abnormal in only one patient 
(1%) with residual unbypassed disease, and we believe 
in all other patients the flows were adequate. 
The apparently greater prevalence of sternal 
wound complications in our study compared with 
other studies in which bilateral ITA grafts were 
used 23-26 lies perhaps in our definition, because we 
included in our definition wounds that failed to heal 
primarily regardless of the bacteriologic evidence of 
infection. When wound complications are limited to 
culture-positive ones, the overall incidence is 6.1% 
(7/116) and is similar to that of other reports. 
Wound complications were more frequent in pa- 
tients with diabetes. Accordingly, since 1993 the 
combination of the left ITA and right gastroepiploic 
artery has been chosen for patients with diabetes 
requiring insulin or oral hypoglycemic agents, al- 
though we have not analyzed the difference. 
We conclude that bringing the right ITA via the 
transverse sinus for grafting the circumflex area 
provided excellent early patency and good clinical 
results and should be considered the procedure of 
choice when revascularization for multivessel dis- 
ease is undertaken. 
We thank A. T. Miyamoto, MD (Kokura Memorial 
Hospital), for his critical review of the manuscript and for 
editorial help. 
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SAFE REMOVAL OF THE RADIAL ARTERY FOR MYOCARDIAL REVASCULARIZATION: A 
DOPPLER STUDY TO PREVENT ISCHEMIC COMPLICATIONS TO THE HAND 
Paolo Pola, MD a 
Michele Serricchio, MD a 
Roberto Flore, MD a 
Eric Manasse, MD b 
Angela Favuzzi, MD a 
Gian Federico Possati, MD b 
Radial artery harvesting has recently been reintroduced for myocardial 
revascularization. Harvesting the radial artery may jeopardize the vascu- 
larization of the hand; cautious selection of candidates must therefore be 
pursued. The study involved 188 consecutive patients. We verified the 
patency of the upper limb's arteries and the adequacy of the ulnar supply 
by static and dynamic Doppler evaluations. The use of the radial artery was 
contraindicated in 14 cases (three for stenosis of the subclavian artery and 
11 for inadequate collateralization). One hundred patients were operated 
on with the radial artery used as a graft; the remaining 74 patients had a 
different conduit placed. The vascularization of the hand was restudied 
within 10 days in all patients who underwent operation; in 63 patients, it 
was studied again at 1 year. The early Doppler examination showed 
significant increase in blood flow velocities in the ulnar artery, with a flow 
redistribution in the common digital palmar arteries (decreased in the first 
and increased in the second and the third). The late Doppler examination 
showed superimposable findings. No local ischemic complications were 
observed. We conclude that Doppler study is a useful tool in preoperative 
screening of candidates for radial artery harvesting for myocardial revas- 
cularization. (J Thorac Cardiovasc Surg 1996;112:737-44) 
T he radial artery (RA) was recently reintroduced as a graft source for coronary artery bypass 
grafting (CABG). 1' 2 Among of the characteristics 
favoring the use of this vessel are a caliber similar to 
that of the major coronary arteries, adequate thick- 
ness and resistance of the arterial wall, and sufficient 
length to allow complete myocardial revasculariza- 
t ion)' 4 For reasons of safety, the nondominant arm 
is used. The entire RA, with satellite veins, is 
removed from its origin at the level of the brachial 
artery to the wrist. 5 Circulations of the forearm and 
hand are acutely deprived of an important artery, 
with possible ischemic consequences ither during 
the early postoperative period or later. To avoid 
ischemic complications to the hand, some authors 
have proposed preliminary evaluation of the palmar 
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circulation by means of an Allen test or a Doppler 
study.6, 7
In our opinion, a more nearly complete vascular 
examination is advisable because of the promising 
results of this surgical technique. The presence of 
atherosclerotic lesions of the RA and of the subcla- 
vian, axillary, brachial, and ulnar arteries hould be 
explored because patients with ischemic myocardial 
disease have a higher rate of peripheral vascular 
disease. It is therefore essential to evaluate the 
palmar circulation and the adequacy of the blood 
supply to the hand provided by the ulnar artery. 
Vascularization of the hand is predominantly ulnar 
in most subjects, and the RA and ulnar artery are 
widely anastomosed at the level of the hand by 
means of the superficial and deep palmar arches, 
with good hemodynamic compensation should ei- 
ther artery be excluded. 7' 8 Anatomic variations (RA 
predominance, incomplete superficial palmar arch, 
and malformations of the ulnar artery) may, how- 
ever, impair appropriate hemodynamic compensa- 
tion when the RA is removed?' 10 The aim of this 
study was to establish objective criteria for safe RA 
harvesting through assessment of the anatomic in- 
tegrity of the arteries of the upper limb with Dopp- 
ler static evaluation and of the adequacy of collat- 
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eral circulation during RA compression (RAC) with 
a Doppler dynamic test (DDT). 
Patients and methods 
Between January 1993 and June 1995, 188 consecutive 
patients (152 male and 36 female) among those admitted 
at the Catholic University of Rome for isolated CABG 
were included in this study. The mean age was 57.9 years 
(range 39 to 76 years). In each patient, the vascularization 
of the upper nondominant arm was evaluated according to 
the standard technique by means of continuous wave 
Doppler equipment (model Dop 2000, Cardioline, Remco 
Spa, Milano, Italy) equipped with a probe at a frequency 
emission of 8 MHz. TM 12 The DDT was performed with 
the patient's hand only slightly flexed and relaxed. All 
examinations were performed by three fully trained angi- 
ologists of the Angiology Department during the same 
hospitalization for CABG. The examinations were per- 
formed with the patients in the supine position after 10 
minutes of rest at a room temperature of 22 ° to 24 ° C. 
Patency of the upper limb arteries was studied by mea- 
suring blood flow velocities along the RA and subclavian, 
axillary, brachial, and ulnar arteries. The following DDT 
was used: either under basal conditions or during RAC at 
the wrist, blood flow velocities were measured at the 
following sites: (1) ulnar artery, at the wrist; (2) superficial 
palmar branch of the RA (SPA), located along an imag- 
inary line following the proximal segment of the second 
metacarpal; (3) main artery of the thumb (I ray), located 
at the base of the thumb on the medial side; (4) second 
common palmar digital artery (II ray), located between 
the heads of the second and third metacarpals; and (5) 
third common palmar digital artery (III ray), located 
between the heads of the third and forth metacarpals. In 
each artery, the following Doppler parameters were con- 
sidered: (1) peak systolic velocity (PSV), expressed in 
centimeters per second; (2) end-diastolic velocity (EDV), 
expressed in centimeters per second; and (3) resistance 
index (RI), derived as (PSV - EDV)/PSV. 
Patients without an increase in blood flow velocity at 
the ulnar artery associated with flow disappearance at the 
SPA during the RAC were considered unsuitable as 
candidates for RA harvesting. Among those patients 
judged to be suitable candidates for RA harvesting, 74 
were excluded by the cardiac surgeons for the following 
reasons: a suitable saphenous vein graft could be found, 
other arterial conduits (right internal thoracic artery, 
gastroepiploic artery, inferior epigastric artery) were pre- 
ferred, or the nondominant arm RA had to be cannulated 
by the anesthetist for blood-pressure monitoring. One 
hundred patients underwent myocardial revascularization 
with the RA. A first clinical examination and a Doppler 
evaluation were performed 10 days after operation to 
evaluate the adequacy of the palmar circulation and the 
presence of ischemic complications. In 63 patients, the 
same evaluation was repeated 1 year later. 
Statistical analysis. Results are expressed as mean 
values (+ standard eviation). The differences between 
two means were compared with Student's t test. The 
criterion for statistical significance was a p value lower 
than 0.05. 
Results 
Among the 188 patients considered in this study, 
three (1.6%) showed an important PSV decrease in 
all the examined arteries of the upper limb, sugges- 
tive of atherosclerotic stenosis of the subclavian 
artery, and were therefore excluded before any 
further investigation; the other 185 had normal flow 
velocities under basal conditions. These 185 patients 
could be placed into two groups, depending on their 
response to the DDT: 174 patents (group A; 
94.05%) were considered suitable candidates for 
RA harvesting, and 11 patients (group B; 5.95%) 
were rejected as candidates because of an inade- 
quate ulnar supply (no increase in blood flow veloc- 
ity at the ulnar artery associated with flow disap- 
pearance at the SPA). Continuous wave Doppler 
tracings of patients with adequate (group A) and 
inadequate (group B) compensation are shown in 
Figs. 1 and 2, respectively. 
Table I shows the average values (_  standard 
deviation) of basal Doppler parameters ( tatic eval- 
uation). The two groups showed similar values of 
PSV, EDV, and RI in all the examined arteries. 
Table II summarizes the results obtained during 
the DDT for each group. Group A had the following 
findings for PSV: a significant increase at the ulnar 
artery (p < 0.0001), a significant decrease at the I 
ray and II ray arteries (p < 0.001), no changes at the 
III ray artery, and presence of retrograde flow at the 
SPA. Group A had the following findings for EDV: 
a significant increase at the ulnar artery (p < 
0.0001), a slight reduction at the I ray artery (p < 
0.05), and no changes at the II ray and III ray 
arteries. Group A had the following findings for RI: 
slight reduction at the ulnar artery (p < 0.05), slight 
increase at the I ray artery (p < 0.05), and no 
changes at the II ray and III ray arteries. 
Group B showed the following findings for PSV: 
no increase at the ulnar artery, a significant decrease 
at the II ray and III ray arteries (p < 0.0001), a slight 
reduction at the III ray artery (p < 0.05), and flow 
disappearance at the SPA. Group B showed the 
following findings for EDV: no changes at the ulnar 
artery, a decrease at the I ray and II ray arteries (p < 
0.05), and a more evident decrease at the III ray 
artery (p < 0.001). Group B showed the following 
findings for RI: no changes at the ulnar artery and at 
the ! ray artery and a slight increase at the II ray and 
III ray arteries. 
Table III shows the comparison between basal 
and postoperative (at 10 days and after 1 year) 
average values of PSV, EDV, and RI in the exam- 
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Fig. 1. Doppler tracings of a patient with adequate ulnar supply during DDT. c, RAC; d, RA 
decompression. 
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Fig. 2. Doppler tracings of a patient with inadequate ulnar supply during DDT. c, RAC; d, RA  
decompression. 
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ined arteries. After 10 days, we observed significant 
increases in PSV and EDV at the ulnar artery, with 
an important reduction in RI (p < 0.0001). At the 
SPA, we observed a reverted flow. At the I ray 
artery, we observed a slight PSV decrease (p < 0.05) 
and no changes in EDV and RI. At the II ray artery, 
slight increases in PSV and EDV and a decrease in 
RI (p < 0.05) were noted. We observed slight PSV 
and EDV increases (p < 0.05) and no changes in RI 
at the III ray artery. 
The results at 1 year after the operation showed 
significant increases in PSV (p < 0.0001) and EDV 
(p < 0.05) at the ulnar artery, with a reduction in RI 
(p < 0.001). At the SPA, we observed a reverted 
flow. At the I ray artery, a slight PSV decrease was 
observed (p < 0.05), with no changes in EDV and 
RI. No change in PSV, a slight increase in EDV 
(p < 0.05), and a decrease in RI (p < 0.0001) were 
observed at the II ray artery. At the III ray artery, we 
observed slight PSV and EDV increases (p < 0.05), 
with a decrease in RI (p < 0.0001). 
Table IV shows the comparison between flow 
values obtained during DDT and at 1 year follow- 
up. At the ulnar artery and at the SPA, no significant 
differences in PSV, EDV, and RI were seen. At the 
I ray artery, a higher PSV (p < 0.0001), a higher 
EDV (p < 0.0001), and a lower RI (p < 0.0001) 
were seen at 1 year. A higher PSV (p < 0.0001), a 
higher EDV (p < 0.001), and a lower RI (p < 
0.0001) were also seen at 1 year at the II ray artery. 
At the III ray artery, we similarly observed increased 
PSV (p < 0.0001), increased EDV (p < 0.0001), and 
decreased RI (p < 0.0001) at 1 year. 
Clinically, no ischemic omplications of the hand 
were found, either in the immediate postoperative 
phase or after 1 year. 
Discussion 
In patients undergoing CABG, accurate vascular 
evaluation before RA removal is useful to confirm 
the patency of the artery to be used as a bypass graft 
and to avoid ischemic complications to the hand. 
Contraindications to the use of the RA were as 
follows: atherosclerosis of the upper limb arteries, 
anatomic variations of the arterial circulation of the 
hand and forearm potentially limiting adequate 
ulnar supply, and Raynaud's disease. Only the non- 
dominant arm was examined because the cardiac 
surgeons chose to wait for longer follow-up before 
considering the use of both arms. 5 We performed a
continuous wave Doppler static evaluation of the 
arteries of the upper limb and a DDT of the ulnar 
Table I. PSV, EDV, and RI in examined arteries 
under basal conditions, in the patients considered 
suitable for RA (group A) and in those rejected 
(group B) 
Group A Group B 
(n = 174) (n = 11) p 
Brachial 
PSV 55.80 +_ 11.70 54.70 _+ 3.23 NS 
EDV 1.30 ± 3.10 1.35 ± 2.46 NS 
RI 0.98 ± 0.05 0.98 ± 0.40 NS 
Radial 
PSV 37.82 _+ 11.93 34.50 ± 4.50 NS 
EDV 1.90 ± 4.26 1.60 ± 1.46 NS 
RI 0.96 _+ 0.09 0.95 _+ 0.04 NS 
Ulnar 
PSV 32.60 _+ 11.71 31.10 _+ 6.87 NS 
EDV 2.15 ± 4.42 0.58 _+ 1.41 NS 
RI 0.95 _+ 0.11 0.99 ± 0.04 NS 
SPA 
PSV 23.39 ± 6.22 24.12 ± 5.49 NS 
EDV 1.30 ± 2.81 1.57 +_ 2.18 NS 
RI 0.96 ± 0.10 0.95 ± 0.15 NS 
I ray 
PSV 16.60 _+ 8.10 17.10 _+ 3.74 NS 
EDV 1.39 _+ 3.21 1.65 ± 1.45 NS 
RI 0.94 _+ 0.10 0.90 ± 0.14 NS 
II ray 
PSV 16.70 ± 6.80 17.12 ± 7.30 NS 
EDV 1.40 ± 2.60 1.27 ± 1.61 NS 
RI 0.93 ± 0.10 0.91 ± 0.10 NS 
III ray 
PSV 17.10 ± 6.70 18.42 ± 9.04 NS 
EDV 1.20 ± 2.60 1.74 ± 0.77 NS 
RI 0.94 ± 0.10 0.89 _+ 0.15 NS 
Values are mean +_ standard eviation. 
artery, SPA, and common palmar digital arteries 
during RAC. Because of the increasing use of RA 
grafts, we consider our proposed Doppler evalua- 
tion to be more worthwhile and safer, yet negligibly 
more costly in terms of time to perform and expense 
incurred, than the Allen test alone. The Allen test 
does not allow reliable evaluation of the single 
arteries of the hand, and it has long been criticized 
for its considerable rate of false-positive and false- 
negative results. 13-16 A more detailed analysis of 
each artery can undoubtedly be obtained with 
Doppler evaluation. 14 Examination under basal con- 
ditions allows the identification of atherosclerotic 
lesions, which in our opinion should constitute an a 
priori criterion for exclusion of patients from this 
procedure. Patients with such lesions would be more 
susceptible to embolic episodes, which could be 
catastrophic n the presence of a single blood supply 
7 4 2 Pola et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1996 
Table II. PSV,, EDV, and RI changes in examined arteries during RAC in patients considered suitable for RA 
harvesting (group A) and in those rejected as candidates (group B) 
Group A Group B 
(n = 174) (n = 11) 
Basal RA C p Basal RA C p 
Ulnar 
PSV 32.60 + 11.71 47.20 -+ 14.50 <0.0001 31.10 ,+ 6.87 32.10 _+ 8.22 NS 
EDV 2.15 .+ 4.42 4.80 + 6.70 <0.0001 0.58 _+ 1.41 0.25 _+ 0.71 NS 
RI 0,95 _+ 0.11 0.91 _+ 0.13 <0.05 0.99 _+ 0.04 0,99 -+ 0.02 NS 
SPA 
PSV 23.39 _+ 6.22 -5,50 _+ 11.60 <0.0001 24.12 _+ 5.49 0.00 -+ 0.00 <0.0001 
EDV 1.30 _+ 2,81 0.00 _+ 0.00 <0.0001 1.57 _+ 2,18 0.00 _+ 0.00 <0.0001 
RI 0.96 +_ 0,10 1.00 _+ 0.00 <0.0001 0,95 _+ 0.15 0.00 -+ 0.00 <0.0001 
I ray 
PSV 16.60 _+ 8.10 9.00 _+ 5,90 <0,001 17.10 +_ 3.74 1.25 _+ 2.10 <0.0001 
EDV 1.39 .+ 3.21 0.40 _+ 1.70 <0,05 1.65 _+ 1.45 0.13 -+ 0.30 <0,05 
RI 0,94 _+ 0.10 0.98 -+ 0.10 <0.05 0.90 .+ 0.14 0.83 -+ 0.30 NS 
II ray 
PSV 16,70 _+ 6.80 12.20 ,+ 6.80 <0.001 17.12 _+ 7.30 1.00 ,+ 1.50 <0.0001 
EDV 1.40 _+ 2.60 0.90 _+ 2.50 NS 1.27 ,+ 1.61 0.00 ,+ 0.00 <0.05 
RI 0.93 _+ 0.10 0.95 _+ 0.10 NS 0.91 .+ 0.10 1.00 -+ 0.00 <0.05 
III ray 
PSV 17.10 ,+ 6.70 16.00 _+ 6.80 NS 18.42 _+ 9.04 7.25 -+ 7.70 <0.05 
EDV 1.20 ,+ 2.60 1.20 _+ 2.60 NS 1.74 _+ 0.77 0.00 -+ 0.00 <0,001 
RI 0.94 _+ 0.10 0,94 _+ 0.10 NS 0.89 _+ 0.15 1.00 _+ 0.00 <0.05 
Values are mean _+ standard eviation. 
Table III. Comparison between basal and postoperative values of PSV, EDV,, and RI in examined arteries 
Basal 10 days I yr 
(n = 174) (n = 100) p (n = 63) p 
Ulnar 
PSV 32.60 .+ 11.71 52.60 -+ 14.60 <0.0001 44.60 _+ 12.40 <0.0001 
EDV 2,15 _+ 4.42 7.80 -+ 8.60 <0.0001 5.20 _+ 6.40 <0.05 
RI 0,95 -+ 0.11 0.87 -+ 0.10 <0.0001 0.89 _+ 0.10 <0.001 
SPA 
PSV 23.39 -+ 6,22 -10.40 ,+ 15.33 <0.0001 -6.81 _+ 13.59 <0.0001 
EDV 1.30 -+ 2.81 0.00 -+ 0.00 <0,0001 0.00 _+ 0,00 <0.0001 
RI 0.96 -+ 0.10 1.00 -+ 0.00 <0.0001 1,00 _+ 0.00 <0.0001 
I ray 
PSV 16,60 _+ 8.10 12.70 -+ 8.70 <0.05 11,90 ,+ 5.70 <0.05 
EDV 1.39 _+ 3.21 1.80 -+ 3.90 NS 1.40 _+ 2.60 NS 
RI 0.94 ,+ 0.10 0.93 -+ 0.10 NS 0.91 ,+ 0.10 NS 
II ray 
PSV 16.70 -+ 6.80 18.80 -+ 8.40 <0.05 16.30 _+ 6.60 NS 
EDV 1.40 -+ 2.60 2.90 -+ 4.70 <0.05 2.20 + 3.20 <0.05 
RI 0.93 -+ 0.10 0.89 -+ 0,20 <0.05 0.87 _+ 0.10 <0.0001 
III ray 
PSV 17.10 _+ 6.70 19,60 _+ 8.08 <0.05 19.30 _+ 7.40 <0.05 
EDV 1.20 -+ 2.60 2.50 -+ 4.60 <0.05 3.10 -- 4.10 <0.05 
RI 0.94 -+ 0.10 0.91 -+ 0.20 NS 0.86 _+ 0.20 <0.0001 
Values are mean + standard eviation. 
to the forearm. For this reason, three patients 
(1.6%) with significant stenosis of the subclavian 
artery were withdrawn from the study after the basal 
Doppler evaluation. 
To further screen patients placed at risk by RA 
removal because of inadequate collateralization, the 
DDT was employed. This test can thoroughly ex- 
plore efficiency of terminal anastomosis between the 
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radial and ulnar territories. In our opinion, RA 
removal was contraindicated when the following 
conditions were concomitantly present under condi- 
tions of RAC: (1) absence of the expected PSV and 
EDV increases in the ulnar artery and (2) disap- 
pearance of the flow in the SPA. The association of 
these two criteria, as observed in 5.95% of patients, 
suggests inadequacy of the superficial palmar arch 
and the absence of other anastomotic sites between 
the ulnar and RA. 
Patients without these associated findings 
(94.05%) were judged suitable candidates for RA 
harvesting. Among these patients, the best stan- 
dards of flow modifications were as follows: a sys- 
tolic-diastolic increase in flow rate in the ulnar 
artery of 20% or more, a reversed flow at the level of 
the SPA, a stable flow in the III ray artery, and 
reductions of as much as 70% of the original value in 
the I! ray and as much as 30% in the I ray. The 
increase in systolic-diastolic velocities in the ulnar 
artery after RAC at the wrist suggests a good 
compliance of the artery, one able to receive the 
entire flow from the brachial artery, adapting the 
flow velocity to the increased volume. The presence 
of reversed flow at the superficial palmar branch of 
the RA indicates the anatomic ontinuity of the 
superficial palmar arch. A complete superficial pal- 
mar arch was found in 93% of the patients in group 
A. The remaining 7% showed a decreased flow 
during RAC, which was still considered suitable 
because the ulnar flow increase offered a good 
anastomotic supply. 
Further information isprovided by the analysis of 
the flow patterns een in the common digital palmar 
arteries during RAC. An unchanged flow velocity at 
the Ill ray artery, with a slight reduction at the II ray 
and I ray, suggests a good palmar circulation even 
after RA removal. Finally, the main contraindica- 
tion to RA removal is an inadequate ulnar flow 
increase; other criteria are of secondary importance 
and must coexist rather than being considered sep- 
arately to reach significance. Follow-up analysis 
confirms the utility of the tests we carried out. The 
check-up conducted 10 days after the operation 
showed a marked increase of PSV and EDV, with 
significant reduction of the RI at the ulnar artery, 
probably as a result of reactive vasodilatation and 
local inflammation after the operation. The varia- 
tions observed at level of the SPA and the common 
digital palmar arteries reflect he new arrangement 
of regional hemodynamics: reverted (in 90% of 
patients) or decreased flow in the SPA (in 10% of 
Table IV. Comparison between RAC and 
postoperative (1year) values of PSV, EDV, and RI 
RA C l yr 
(n = 174) (n = 63) p 
Ulnar 
PSV 47.20 _+ 14.50 44.60 +_ 12.40 NS 
EDV 4.80 _+ 6.70 5.20 _+ 6.40 NS 
RI 0.91 _+ 0.13 0,89 +_ 0.10 NS 
SPA 
PSV -5,50 _+ 11.60 -6.81 _+ 13.59 NS 
EDV 0,00 _+ 0.00 0.00 _+ 0.00 NS 
RI 1,00 ± 0.00 1.00 ± 0.00 NS 
I ray 
PSV 9,00 ± 5.90 11.90 ± 5.70 <0.0001 
EDV 0.40 _+ 1.70 1.40 _+ 2.60 <0.0001 
RI 0,98 +_ 0,10 0.91 _+ 0.10 <0.0001 
II ray 
PSV 12.20 _+ 6.80 16.30 _+ 6.60 <0.0001 
EDV 0.90 _+ 2.50 2.20 _+ 3.20 <0.001 
RI 0.95 _+ 0.10 0.87 +_ 0.10 <0.0001 
II I  ray 
PSV 16.00 ± 6.80 19.30 _+ 7.40 <0.0001 
EDV 1.20 ± 2.60 3.10 _+ 4.10 <0.0001 
RI 0.94 _+ 0.10 0.86 _+ 0.20 <0.0001 
Values are mean -+ standard eviation. 
patients), increased flow velocities at the II ray and 
Ill ray arteries, and decreased flow velocities at the 
I ray artery. One year after operation, the ulnar 
artery had persistent increases in blood flow veloc- 
ities. The EDV decreased compared with the veloc- 
ity observed during the immediate postoperative 
period because of disappearance of inflammation. 
The behavior of the overall flow of the SPA and the 
common digital palmar arteries is similar to that 
observed at the first examination, during RAC. The 
definitive interdigital flow rate redistribution can be 
predicted with great accuracy by means of preoper- 
ative DDT, although the absolute values registered 
at 1 year are superior because the collateral circu- 
lation adapts its capacity with time. The clinical 
relevance of this flow redistribution to the hand 
must be analyzed over a longer interval. The instru- 
mental tests results are confirmed by current clinical 
observations: no patient reported any circulatory 
disturbance. 
In conclusion, safe RA removal for CABG is 
better ensured in the absence of atherosclerotic 
lesions of the upper limb's arteries and of anatomic 
variations of the palmar circulation. In our opin- 
ion, a Doppler static evaluation and the DDT that 
we propose are the best tools to verify these 
conditions. 
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LONG-TERM RESULTS OF RECONSTRUCTIONS OF THE LEFT ANTERIOR DESCENDING 
CORONARY ARTERY IN DIFFUSE ATHEROSCLEROTIC LESIONS 
O~uz Ta~demir, MD a 
U~ursay Kiziltepe, MD a 
Haldun Y. Karag6z, MD a 
Birol Yamak, MD a 
~ule Korkmaz, MD b 
Kemal Bayazit, MD a 
One hundred twenty patients who had diffuse atherosclerotic lesions 
necessitating reconstruction of the left anterior descending artery with or 
without open endarterectomy and coronary artery bypass grafting were 
investigated retrospectively and compared with 130 patients who underwent 
conventional bypass grafting in the same time frame. Methods: Sixty-one 
endarterectomies were performed with long arteriotomies (group I) and 59 
patch reconstructions were placed over stenosing plaques without an 
endarterectomy (group II). Patients having only conventional coronary 
bypass constituted group III. Results: Hospital mortalities were 6.5%, 5.1%, 
and 1.5% in group I, group II, and group III, respectively (p = not 
significant). Five patients in group I (8.1%), six in group I I  (10.1%), and two 
in group I I I  (1.5%) had perioperative myocardial infarction (group II vs 
group III, p = 0.016). Angiographic restudy of grafts to the left anterior 
descending system revealed a patency rate of 81.5% in group I, 79.1% in 
group II, and 94.4% in group I I I  patients after mean periods of 6.3, 5.7, and 
6.1 years, respectively (p = not significant). Actuarial survivals at 7 years 
were 94% - 5.0%, 74.8% - 16%, and 90.9% - 7.4% in groups I, II, and III, 
respectively (group I vs group II, p = 0.007; group II vs group III, p -- 
0.008). Freedom from recurrent angina at 7 years was 42.7% -+ 15.6% in 
group I, 33.5% - 19% in group II, and 71.9% - 14.2% in group II I  (group 
I vs group III, p = 0.03; group I I  vs group III, p = 0.0001). Thirty-four 
percent of patients in group I, 24% in group II, and 60.4% in group I I I  were 
working actively in the late postoperative period (p = 0.0001). Conclusion: 
Extended revascularizations of the left anterior descending coronary artery 
increase surgical risk, although not to a statistically significant degree, and 
should be performed only of necessity. However, once needed, revascular- 
ization is a lifesaving procedure with acceptable arly and long-term 
results. (J Thorac Cardiovasc Surg 1996;112:745-54) 
S everal studies indicate that patients with diffuse coronary artery disease (CAD) in whom stan- 
dard coronary bypass techniques cannot be per- 
formed constitute 0.8% to 25.1% of all patients with 
CAD.  1-3 
Endarterectomy and reconstruction of the left 
anterior descending (LAD) coronary artery is a 
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time-consuming, meticulous, and more challenging 
procedure than conventional coronary artery bypass 
grafting (CABG), and its feasibility is controversial. 3 
However, the expansion in the indications for sur- 
gical therapy of severe and diffuse CAD has resulted 
in a revival of interest in coronary artery endarter- 
ectomy. 4 It may be the only therapeutic option for 
some patients whose condition is otherwise deemed 
inoperable. 
To assess the early and late results of different 
reconstruction techniques of the LAD artery, we 
retrospectively investigated and presented the case 
histories of 250 patients in three groups. 
Patients and methods 
Between 1988 and 1992, 4200 patients with CAD un- 
derwent myocardial revascularization at this institution. 
745 
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Table  I. Preoperative characteristics of patients 
Group I Group H Group III 
No. of patients 61 59 
Female (%) 11 10 
Mean age (yr) 53.6 + 13.7 54.2 _+ 12.3 
Class I (%) 8 5.1 
Class II (%) 46 54.2 
Class III (%) 36 32.2 
Class IV (%) 10 8.5 
One-vessel disease 8 10 
(%) 
Two-vessel disease 33 25 
(%) 
Three-vessel dis- 59 65 
ease (%) 
Severe LV dys- 13 7 
function (%) 
Hypertension (%) 26 27 
Smoking (%) 57 (p = 0.03*) 56 (p = 0.043t) 
Diabetes (%) 21 28 (p = 0.005t) 
Family history 28 15 
(%) 
Hyperlipidemia 34 32 
(%) 



















Class, Clinical angina class of patients according tothe Canadian Cardio- 
vascular Society; LV, left ventricular. Only statistically significant p values 
are indicated. 
*Group I versus group III. 
tGroup II versus group III. 
One hundred twenty patients (3%) required isolated 
patch reconstruction of the LAD artery with or without 
coronary endarterectomy. Sixty-one patients underwent 
LAD artery endarterectomy under direct vision with long 
arteriotomies (group I); 59 were subjected to LAD artery 
patch reconstructions placed over stenosing plaques with- 
out an endarterectomy (group II). For comparison, a
control group including 130 patients (group III) was 
constituted randomly among patients subjected to stan- 
dard CABG techniques during the same time period and 
by the same surgical teams. There was one reoperation i  
both group I and group III. 
Patients who underwent additional endarterectomies 
and reconstructions of arteries other than the LAD artery, 
as well as accompanying procedures uch as left ventric- 
ular aneurysmectomy or valve replacement, were ex- 
cluded from the study groups. Preoperative characteristics 
of the groups are depicted in Table I. 
Surgical procedure. Standard median sternotomy and 
aorta-right atrial cannulation were performed after car- 
diopulmonary bypass was instituted. Patients were cooled 
to 29 ° to 31 ° C and cold saline solution was used intra- 
pericardially for topical cooling of the myocardium. Re- 
vascularization procedures were performed with aortic 
crossclamping and cardioplegic arrest. Myocardial protec- 
tion was achieved by induction of cardioplegia with cold 
crystalloid cardioplegic solution followed by a combina- 
Tab le  I I .  Operative characteristics of all three 
groups 
Group t Group H Group III 
Mean No. of 2.7 _+ 0.4 3.1 _+ 0.9 2.9 _+ 0.3 
anastomoses 
Mean length of 7.1 _+ 1.8 4.3 _+ 1.2 - -  
reconstruction (cm) 
ITA PP 48 56 - -  
ITA+SV PP 6 0 - -  
Ao-SV PP 7 3 - -  
Reoperation 1 0 1 
Free ITA 3 2 5 
ITA PP, LAD artery reconstructions with ITA; ITA+SVPP, LAD artery 
reconstruction with saphenous vein patch and an ITA anastomosis; Ao-SV 
PP, aorta-LAD artery saphenous bypass and patch reconstruction. 
tion of antegrade plus retrograde blood cardioplegia, and 
cardioplegic arrest was terminated by a terminal dose of 
retrograde warm blood cardioplegia. 
Group I. If the atherosclerotic process involved the 
distal LAD artery or obstructed the intermediate, septal, 
and diagonal tributaries and there was no suitable place to 
construct a conventional nastomosis, a long arteriotomy 
was made and extended until nondiseased arterial umen 
was reached. If the diffuse occlusion included the main 
septal perforator artery, occasionally the arteriotomy was 
extended more proximally to this level and the ostium was 
exposed. If the occlusion extended into the diagonal 
artery, the arteriotomy was extended until the end of 
plaque was reached. 
After arteriotomy, the cleavage between the plaque and 
vessel wall was found. They were gently separated, and the 
atherosclerotic material was removed under direct vision 
without raction or countertraction f the endarterectomy 
core. No special device was used. Margins of endarterec- 
tomy specimens were examined carefully to see whether 
the distal end tapered or feathered. If the end was not 
tapered, the arteriotomy was extended toward the apex 
and residual atherosclerotic material was removed. 
It was deemed crucial to avoid residual dissecting layers 
and not to leave residual plaques with separated ends. Once 
an ideal plane was established, plaques at the openings of 
septal perforators were easily removed with good tapering 
ends because continuities of atheromatous core at septal 
arteries generally were not longer than 0.5 cm. 
After establishment of a smooth lumen free of athero- 
sclerotic material, three different techniques of recon- 
struction were used (Table II). 
1. If the internal thoracic artery (ITA) was long enough, 
an extended patch anastomosis was constructed over the 
arteriotomy alone with a single running 7-0 or 8-0 poly- 
propylene suture. During the procedure care was taken to 
rebuild a new artery with an optimal diameter not much 
wider than that of the native healthy artery to avoid the 
unfavorable hemodynamic effects of diameter discrepan- 
cies. This procedure was performed on 48 patients. Three 
patients had an ITA shorter than needed and these grafts 
were used as free grafts. 
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2. Six long arteriotomies were closed with a longitudi- 
nally opened saphenous vein segment with a single run- 
ning 7-0 or 8-0 polypropylene suture. Care was taken to 
avoid creating too patulous alumen. After reconstruction, 
an ITA graft was anastomosed onto the saphenous vein 
patch. 
3. In nine patients, the ITA was not used and an 
aorta-coronary saphenous vein bypass graft was con- 
structed over an extended arteriotomy of the LAD artery 
by means of the same method. 
Group II. If the patient had additional stenosing plaque 
or plaques localized distally and an endarterectomy 
seemed unnecessary, a long arteriotomy over occlusive 
plaque or plaques was preferred. The artery was recon- 
structed with a patch rather than multiple anastomoses 
proximal and distal to this plaque. This technique was 
used in 59 patients. In 56 patients an ITA graft was used 
as an onlay patch, and in two of them the ITA was used as 
a free graft; three arteries were reconstructed with the 
distal end of the aorta-LAD saphenous vein bypass graft. 
Postoperative care was routine. Dipyridamole 75 mg 
three times a day and 250 mg acetylsalicylic acid daily 
were given in the postoperative p riod after removal of 
the chest tubes. Anticoagulants were not used. Special 
emphasis was given to early diagnosis of myocardial 
ischemia s evidenced by the electrocardiogram, measure- 
ments of myocardial isoenzymes, and the clinical status of 
the patients. Attention was paid to the location of the 
infarction, whether it was a result of an occlusion of 
endarterectomized or reconstructed artery or an occlusion 
of another artery that had been revascularized with a 
standard anastomosis. As soon as a perioperative myocar- 
dial infarction was documented, heparin (1000 IU/hr) and 
nitroglycerin were given intravenously. An intraaortic 
balloon pump was inserted if necessary. 
Data analysis and follow-up. Anginal status of patients 
was classified as described by the Canadian Cardiovascu- 
lar Society and analyzed before and after the operation, s 
Perioperative myocardial infarction was defined as persis- 
tent electrocardiographic changes as described by The 
Minnesota Code. 6 All patients received follow-up exami- 
nations 2 months and 8 months after the operation and 
yearly thereafter. Follow-up was completed with patient 
questionnaires and direct contact by telephone. Anginal 
status, postoperative late myocardial infarction, interven- 
tions (such as coronary angiography), and working status 
were determined at late follow-up. Patients who had 
recurrent chest pain were restudied angiographically--38 
patients (64%) in group I, 24 in group II (42%), and 18 in 
group Ill (14%). 
Actuarial survival and actuarial freedom from recurrent 
angina with 95% confidence limits were calculated with 
the life-table method. 7'8 Difference of proportions was 
compared by a test for comparing two proportions and by 
the X 2 test. A p value less than 0.05 was assumed to 
indicate statistical significance. 
Results 
All groups were similar with respect o demogra- 
phy, risk factors, anginal classification, and angio- 
graphic data except for smoking history and diabetes 
Table I lL Early events after LAD artery 
revascularization 
Group I Group II Group III 
% No. % No. % No. 
Hospital mortality 6.5 4/61 5.1 3/59 1.5 2/130 
PMI-overall 8.1 5/61 10.1 6/59,p=0.01" 1.5 2/130 
PMI-LAD 1.6 1/61 5 3/59 - -  
PMMTA PP - -  3.3 2/59 - -  
PMI-Ao-SV PP 14 1/7 - -  
LCO 23 14/61 15 9/59 16 21/130 
IABP 4.9 3/61 5 3/59 0.8 1/130 
Hospital mortality, Thirty-day mortality postoperatively; PMI-overall, total 
incidence of perioperative myocardial infarction; PMLLAD, incidence of 
perioperative myocardial infarction located in areas upplied by the LAD 
artery; PMI-ITA PP, incidence of perioperative myocardial infarction after 
LAD artery reconstructions with ITA patch; PMI-Ao-SVPP, incidence of 
perioperative myocardial infarction after LAD artery reconstructions with 
aorta-saphenous bypass graft; PMI-ITA +SVPP, incidence of perioperative 
myocardial infarction after LAD artery reconstructions with saphenous 
vein patch and an ITA anastomosis; LCO, low cardiac output; /ABP, 
intraaortic balloon pumping. 
*Group II versus group III, 
(see Table I). The operative characteristics of the 
patients are depicted in Table II. 
There were no intraoperative deaths. Four pa- 
tient in group I (6.5%), three in group II (5.1%), 
and two (1.5%) in group I I I  died before hospital 
discharge (p = not significant) (Table III). The 
causes of death are summarized in Table IV. 
The overall prevalence of perioperative myocar- 
dial infarction in groups I, II, and I I I  was 8.1% 
(5/61), 10.1% (6/59), and 1.5% (2/130), respectively 
(group I vs group III, p = 0.055; group I vs group II, 
p = not significant; group II vs group III, p = 0.016). 
Of these, one patient in group ! (1.6%) and three 
patients in group I I  (5%) had a perioperative myo- 
cardial infarction in the region supplied by the LAD 
artery. No patients who underwent endarterectomy 
and extensive patch reconstruction with an ITA had 
a perioperative myocardial infarction in the LAD 
artery area. Fourteen (23%) patients in group I, 9 
(15%) in group II, and 21 in group I l l  (16%) had 
low cardiac output and needed intraoperative and 
postoperative inotropic support (p = not signifi- 
cant). The three groups were similar in their need 
for intraaortic balloon pump support (see Table III). 
Follow-up was 98.2% in group I, 100% in group 
II, and 96.8% in group III, totaling 346.5 patient- 
years in group I, 319.2 patient-years in group II, and 
780.8 patient-years in group III. The mean follow-up 
period was 6.3 years in group I, 5.7 years in group II, 
and 6.1 years in group III. 
During follow-up 75% of patients in group I, 79% 
in group II, and 78% in group I I I  were in Canadian 
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GI vs Gill; p: n.s. 
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Survival % 
70  -G I 98 98 98 94 
G II 100 97.8 94.8 94.8 
G III 97.5 95.5 94.1 94.1 
60 I i i J 
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I 
Years 0 
Patients at Risk 
G I 56 51 44 31 20 11 9 
G II 57 55 39 26 19 10 2 
G III 128 117 86 58 36 22 13 
94 94 94 
88.5 74.8 74.8 
90.9 90.9 90.9 
I I I 
5 6 7 
Fig. 1. Actuarial estimates of survival after coronary artery revascularizations with three different 
techniques. Survival in group I was statistically significantly higher than in group II. Survivals were similar 
in groups I and III. G1, Group I; GII, group II; GIII, group III; n.s., not significant. 
Table IV. Causes of hospital mortality after LAD artery revascularizations with respect to groups and type of 
reconstruction 
Group I Group H Group III ITA PP Ao-SV PP ITA + SV PP 
Cause % No. % No. % No. % No. % No. % No. 
LCO 4.9 3/61 1.6 1/59 0.7 1/130 3.8 4/104 . . . .  
VF  - -  - -  1.6 1/59 0.7 1/130 0.9 1/104 . . . .  
PMI  1.6 1/61 . . . . . . . .  16 1/6 
MOF - -  - -  1.6 1/59 - -  - -  0.9 1/104 . . . .  
Tota l  6.5 4/61 5.1 3/59 1.5 2/130 5.6 6/104 - -  - -  16 1/6 
ITA PP, LAD artery reconstructions with ITA; Ao-SV PP, Aorta-LAD artery saphenous bypass and patch reconstruction; ITA+SV PP, LAD artery 
reconstruction with saphenous vein patch and an ITA anastomosis; LCO, low cardiac output; VF, ventricular fibrillation; PMI, perioperative myocardial 
infarction; MOF, multiorgan failure. 
Cardiovascular Society class I or lI (p = not signif- 
icant). Two patients in group I, four in group II, and 
seven in group IIl died (linearized occurrence rates: 
0.6%/pt-yr, 1.2%/pt-yr, and 0.9%/pt-yr, respective- 
ly). Two patients in group II and one in group III 
died of recurrent myocardial infarction, and two in 
group II and another two in group II1 died of 
congestive heart failure. One patient in group I and 
another patient in group lII died in automobile 
accidents. One patient in group III died of a stroke. 
One patient in group I and two in group III died of 
unknown causes. Actuarial survivals for 7 years with 
95% confidence limits were 94% _+ 5% in group I, 
74.8% + 16% in group II, and 90.9 --- 7.4 in group 
III (group I vs group II, p = 0.007; group I1 vs group 
III, p = 0.008; group I vs group III, p = not 
significant) (Fig. 1). Four patients in group II and 
three in group III had myocardial infarction in the 
late postoperative period (linearized occurrence 
rates: 1.2%/pt-yr and 0.4%/pt-yr, respectively). Two 
patients in group III underwent reinterventions 
(such as coronary angioplasty) (linearized occur- 
rence rate: 0.3%/pt-yr). Actuarial estimates of free- 
dom from recurrent angina pectoris for 7 years with 
95% confidence limits were 42.7% + 15.6% in 
group I, 33.5% + 19% in group II, and 71.9% _+ 
14.2% in group III (group I vs group II, p = not 
significant; group II vs group III, p = 0.0001; group 
I vs group III, p = 0.03) (Fig. 2). Thirty-four percent 
of patients in group l, 24% in group II, and 60.4% in 
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G I 100 97.8 89.9 76 61 42.7 42.7 
G II 100 95.7 92.7 92.7 67.1 33.5 33.5 
G III 99 89 84 75 74 73 72.9 
I I I I I I I 
1 2 3 4 5 6 7 
56 51 44 31 20 11 9 
57 55 39 26 19 10 2 
128 117 86 58 36 22 13 
Fig. 2. Actuarial estimates of freedom from recurrent angina pectoris. Recurrent angina apparently is less 
common in group III patients than in patients from groups I and II. Abbreviations as in Fig. 1. 
V. Follow-up and late results of all groups 
Group I Group H Group III 
Percent follow-up 98.2 100 96.8 
Mean follow-up (yr) 6.3 5.7 6.1 
Late mortality, % (No.) 3.5 (2/57) 7.1 (4/56) 5.6 (7/128) 
0.6%/pt-yr 1.2%/pt-yr 0.9%/pt-yr 
Class I (%) 32 35.7 37 
Class II (%) 43 43 41 
Class III-IV (%) 25 21.3 22 
Re-MI, % (No.) 0 7.1 (4/56) 2.4% (3/128) 
1.2%/pt-yr 0.4%/pt-yr 
Reintervention, % (No.) 0 0 1.6% (2/128) 
0.3%/pt-yr 
Employed (%) 34 23 60.4,p = 0.0001*t$ 
Survival at 7 yr (%) 94 _+ 5 74.8 _+ 1.6 90.9 _+ 7.4p = 0.00St 
p = NS* p = 0.007? 
Angina free (%) 42.7 _+ 15.6 33.5 +_ 19 71.9 _+ 14.2 
p = 0.0001:~ p = 0.03* 
Class, Anginal class of patients according to the Canadian Cardiovascular Society classification; Re-MI, recurrent myocardial infarction; reintervention, any 
nonsurgical revascularization procedure; survival, actuarial survival after 6 years; Angina free, actuarial estimate of freedom from recurrent angina pectoris. 
Events were presented as proportion of number of events to whole group and actuarial and linearized occurrence rates. 
*Group I versus group III. 
tGroup I versus group II. 
:1:Group II versus group III. 
group III were working actively at late follow-up 
(group I vs group II, group I vs group III, group II 
vs group III, p = 0.0001) (Table V). 
Follow-up angiograms revealed patency rates of 
81.5% in endarterectomized LAD arteries of group 
I patients, 79.1% in reconstructed LAD segments of 
group II patients, and 94.4% in grafts running to the 
LAD artery of group III patients after mean periods 
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Fig. 3. Coronary angiogram at 32 months in a patient 
with a 6 cm long open endarterectomy and patch recon- 
struction with the distal end of an ITA graft. The endar- 
terectomy and reconstruction site is between the arrows. 
Regular walls, a lumen with an acceptable width, and good 
filling of septal perforators are noticeable. 
Fig. 4. Coronary angiogram of a patient with open end- 
arterectomy, saphenous vein patch reconstruction, and 
ITA grafting at 37 months after the operation. There is 
overt distortion with irregular walls and aneurysmal dila- 
tations at the patch reconstruction site, which isprone to 
early occlusion. 
of 6.3, 5.7, and 6.1 years, respectively (p = not 
significant). 
During the evaluation of the angiograms we gave 
additional emphasis to the patency of septal perfo- 
rator arteries and their effect on septal wall contrac- 
tility in patients of groups I and II. Sixty-six percent 
of the patients who were evaluated angiographically 
had a patent main septal perforator artery and 58% 
had a normally contracting septal wall. Fifty-three 
percent of patients with occluded septal perforators 
or in whom endarterectomy was not performed 
showed akinesia and dyskinesia, whereas the rest 
showed hypokinesia of the septum. 
We compared the angiographic appearance of the 
extensively endarterectomized LAD artery lumen, 
material used for patch reconstruction, and func- 
tional capacity of patients and noted the following: 
1. Most of the grafts with ITA patch reconstruc- 
tions had a lumen with an acceptable width that did 
not have ectatic or narrow segments that would 
result in poor flow characteristics (Fig. 3). A few 
grafts had shrunken or distorted walls. Some pa- 
tients had patent endarterectomy segments with a 
thin or absent lumen of the distal LAD artery and an 
ITA still patent despite poor runoff. Seven patients 
in group I had a patent endarterectomy bed with 
poor distal runoff and no septal perforators visible. 
Three patients in whom ITAs were used for recon- 
struction in group I had occluded endarterectomy 
beds with patent ITAs. Only two ITAs in group I 
were occluded (6.6%). 
2. Four patients of six with saphenous vein patch 
reconstructions and ITA grafting in group I were 
restudied angiographically. Two of them had an 
irregular and patulous saphenous vein patch wall 
and a nearly occluded endarterectomy bed with a 
patent ITA and an akinetic septal wall. Others had 
a patent reconstructed LAD artery segment with 
irregular walls, patent septal perforators, and a 
normokinetic septum. Extensive aneurysmal dilata- 
tions and stenosing areas in the reconstructed seg- 
ment were noted (Fig. 4). 
3. In group I, five patients with saphenous vein 
bypass grafts to the LAD artery along with endar- 
terectomy and reconstruction were restudied angio- 
graphically, and three showed a patent and irregular 
saphenous vein wall (Fig. 5). No patients in group II 
who had an LAD reconstruction with the same 
method underwent coronary angiography. 
4. Twenty-four restudies were performed on 
group II patients with long patch reconstructions 
with the ITA placed on stenosing plaques. Nineteen 
reconstructed LAD artery segments were patent 
(79.1%). Most showed regular walls and lumina 
similar to those of the native artery (Fig. 6). 
5. Thirty-four percent of the patients in group I, 
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Fig. 5. Coronary angiogram of a patient with open end- 
arterectomy and patch reconstruction with the distal end 
of an aorta-coronary saphenous vein graft at 2 months 
after operation. The lumen at the endarterectomy and 
reconstruction site is irregular and patulous. 
Fig. 6. Coronary angiogram of a patient with patch re- 
construction with ITA over a stenosing plaque without 
endarterectomy. Arrow indicates the end of the patch 
reconstruction site. 
32% in group II, and 28% in group III had progres- 
sion of atherosclerosis of the native coronary artery 
on coronary angiograms (p = not significant). 
Discussion 
Since the inception of myocardial revascularization, 
endarterectomies of coronary arteries have been per- 
formed with or without CABG. 1' 3, 9 After introduction 
of coronary endarterectomy by Bailey, May, and Lew- 
man, 9 several techniques and contradictory results 
were reported. 1'2-4'9-17 Some devices, Is both laser ~9 
and gas, z° were used for endarterectomy. 
If an endarterectomy is performed under direct 
vision with an arteriotomy exposing the whole arte- 
rial lumen and side branches containing atheroscle- 
rotic occlusive material, and if the occlusive material 
is then removed without traction, it is possible to 
avoid residual material in the LAD lumen as well as 
dissections; both could cause early thrombotic oc- 
clusions, perioperative infarctions, and mortality. 
Several techniques have been used to reconstruct 
endarterectomized arteries. At the inception of cor- 
onary artery surgery, coronary arteriotomies were 
closed primarily. 4 Because of the prevalence of 
thrombosis, however, this technique was abandoned 
and arteriotomies were closed with vascular patches. 
Accelerated atherosclerosis, aneurysmal dilatations, 
and resultant turbulence of saphenous vein patches 
also may adversely affect he fate of the reconstruc- 
tion. 21 Whereas ITA grafts have been shown to 
remain patent in the presence of a negligible for- 
ward flow, 22 reduced flow rates through saphenous 
vein grafts resulting from extensive LAD artery 
disease may have a substantial effect on the forma- 
tion of subendothelial proliferative lesions. 23 Patch 
reconstruction of the arteriotomy with an ITA graft 
is the most common technique in our experience. It 
offers better coronary flow characteristics, 24 and the 
patch is a "live" conduitY Patch reconstruction 
provides better vasomotor functions, particularly the 
capability to adjust the flow rate proportional to the 
distal runoff, 22 a widely known paracrine function of 
a living endothelium that produces and releases 
prostacyclin and other endothelium-dependent re- 
laxation factors. 26 The almost negligible incidence 
of atherosclerotic disease of this conduit is another 
advantage. 27Moreover, a better match in diameter 
with the graft, the reconstructed segment, and the 
native coronary artery can be obtained with this 
technique. The resultant flow patterns are better. 
Lower patency and higher morbidity rates after 
coronary artery endarterectomy limit its use to 
arteries that are inoperable by conventional bypass 
techniques. 1'13-16 There are several reasons for 
worse results of endarterectomy than for conven- 
tional anastomoses. Because of the lack of endothe- 
lium, all the subendothelial material that can trigger 
the coagulation cascade is exposed to blood flow. 
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Table VI. Angiographic data. Numbers in the 
parentheses are number of patients angiographically 
studied. Patency rates of ITA grafts and 
reconstructed arteries are calculated independently. 
All comparisons between different subsets revealed 
statistically insignificant differences. 
Patent Occluded 
% No. % No. 
Group I (38/57, 68%) 
Endarterectomy bed 81.5 31/38 18.5 7/38 
ITA grafts 93.4 28/30 6.6 2/30 
Group II (24/56, 43%) 
Reconstructed segments 79.1 19/24 20.9 5/24 
ITA grafts 87 20/23 13 3/23 
Group III (18/128, 14%) 
Grafts to LAD artery 94.4 17/18 5.6 1/18 
ITA PP 90.5 48/53 9.5 5/53 
Ao-SV PP 50 2/4 50 2/4 
ITA+SV PP 60 3/5 40 2/5 
ITA PP, LAD artery reconstructions with ITA; Ao-SV PP, aorta-LAD 
artery saphenous bypass and patch reconstruction; ITA+SV PP, LAD 
artery reconstruction with saphenous vein patch and an ITA anastomosis. 
Some platelet aggregation and fibrin clot formation 
occur in all cases if flow through the lumen is 
sufficient. 28 With poor distal runoff, however, this 
clot formation progresses rapidly with resultant 
thrombosis of the lumen caused by stagnation of 
blood. The absence of substances released from the 
endothelium, such as prostacyclin and nitric oxide, 
which prevent platelet adhesion and aggregation, 
may further contribute to early occlusion. The 
closed endarterectomy technique may result in dis- 
section of the endarterectomized edges, and the 
residual atherosclerotic material in the lumen may 
result in early or late occlusion. Some authors 
emphasized the importance of removal of the end- 
arterectomy core with good tapering ends to prevent 
dissection. 1-3 We also observed that septal wall 
motion was worse in patients in whom the septal 
perforators were occluded than in patients with 
patent septal arteries. 
The diameters of the reconstructed artery, the 
distal native artery, and bypass graft are also impor- 
tant. Patency of the bypass graft has been shown to 
be related to the diameter and flow in the endarter- 
ectomized vessel. TM 29, 3o Usually the reconstructed 
segment is wider than the native artery and is 
dependent on the technique and material used. 
Because of the lack of viable properties and low 
smooth muscle content of the vessel wall, a saphe- 
nous vein patch can easily form aneurysmal dilata- 
tions (see Fig. 4). Resultant urbulence of blood 
flowing from the bypass graft to the reconstructed 
artery and distal bed increases the likelihood of graft 
occlusion. 21 Our experience confirms this point of 
view. We have not observed these kinds of dilata- 
tions on follow-up coronary angiograms of arteries 
reconstructed with ITA patches. We believe that 
ideal flow characteristics an be achieved if the 
artery is reconstructed with an ITA graft. 
Hospital mortality after CABG with coronary 
endarterectomy varied from 4% to 15% and was 
reported to be higher than that of conventional 
bypass techniques, 1' 13-16 despite similar rates re- 
ported by some authors. 1°-12 In our study, hospital 
mortalities after CABG with coronary endarterec- 
tomy (6.5%) and patch reconstruction (5.1%) of the 
LAD artery were comparably higher than after 
conventional bypass (1.5%), although the difference 
did not reach statistical significance. 
The rate of perioperative myocardial infarction 
after coronary endarterectomy was reported to 
range between 5.6% and 13.1% and was generally 
twice that for CABG alone. 1'9 In our series, the 
overall perioperative myocardial infarction rate in 
patients with patch reconstructions without an end- 
arterectomy was statistically significantly higher than 
in patients having conventional bypass (10.1% vs 
1.5%, p = 0.016); by contrast, the difference be- 
tween the open endarterectomy group and the con- 
ventional bypass group did not reach statistical 
significance (8.1% vs 1.5%,p = 0.055). If only areas 
supplied by the LAD artery were taken into account, 
the perioperative myocardial infarction rate in the 
coronary endarterectomy group was only 1.6% and 
was lower than the rate in group II patients (1.6% vs 
5%, p = not significant). Residual atherosclerotic 
material in the distal anastomosis and incomplete 
revascularization may be the reason for the higher 
perioperative myocardial infarction rates in patients 
who underwent patch reconstructions over athero- 
sclerotic plaques. 
Brenowitz, Kayser, and Johnson 1 reported a 
72.6% late patency rate an average of 31 months 
after saphenous vein reconstruction of the LAD 
artery after coronary endarterectomy. Qureshi and 
associates reported the same rate in 58 patients with 
symptomatic disease. Our late patency rates in 
patients having LAD reconstructions (81.5% in 
group I and 79.1% in group II) were not statistically 
significantly ower than the patency rates of grafts to 
the LAD artery in the conventional bypass group 
(94.4%, p = not significant), which demonstrates 
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superiority of ITA  patch reconstruction. Further- 
more, the patency rates of ITA  grafts anastomosed 
to diseased arteries with poor runoff in group I and 
II patients were similar to the patency rates of the 
ITA  grafts in the conventional group (93.4%, 87%, 
and 94.4% in groups I, II, and III, respectively). 
Actuarial survival after CABG with left coronary 
endarterectomy was reported to vary between 
46.5% and 92.5% at 5 years, depending on risk 
factors. 1 Two patients in group I, four in group II, 
and seven in group I I I  died during the late postop- 
erative period. The late mortality in group I was 
probably not related to heart disease, whereas in 
groups I I  and I I I  it often was. Actuarial survival of 
patients with coronary endarterectomy was better 
than that in patients with patch reconstructions over 
plaques at 7 years (94% vs 74.8%, p = 0.008). This 
feature was probably a reflection of the complete 
removal of all atherosclerotic material and complete 
revascularization of the LAD artery in group I 
patients. 
On the other hand, the actuarial estimate of  
f reedom from recurrent angina over the long term 
was significantly higher in group I I I  (see Fig. 2). 
However, life expectancy, functional capacity, and 
working status of patients who underwent endarter- 
ectomy and repair is reasonable and comparable 
with those in group III. 
Conclusion 
The increased complication rate after CABG with 
coronary endarterectomy simply reflects the severe 
and often diffuse nature of the CAD in these 
patients. It is crucial to remove all atherosclerotic 
material under direct vision with open endarterec- 
tomy, paying attention to open orifices of septal 
perforator arteries during the procedure. Our re- 
sults confirm the superiority of LAD artery recon- 
struction. Grafting with an ITA  associated with 
careful endarterectomy technique for coronary re- 
vascularization yields acceptable early and long- 
term results. Because of the natural history of this 
disease, the opportunity for a lifesaving operation 
should be offered to patients who have otherwise 
inoperable diffuse disease of the LAD artery. 
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MORBIDITY OUTCOME IN EARLY VERSUS CONVENTIONAL TRACHEAL EXTUBATION AFTER 
CORONARY ARTERY BYPASS GRAFTING: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL 
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Introduction: We undertook a prospective, randomized, controlled clinical trial to 
evaluate morbidity outcomes and safety of a modified anesthetic technique to 
provide shorter sedation and early extubation (1 to 6 hours) than those of the 
conventional nesthetic protocol used for prolonged sedation and extubation (12 to 
22 hours) in patients after coronary artery bypass grafting. Methods: One hundred 
twenty patients undergoing elective corolmry artery bypass grafting were prospec- 
tively assigned randomly to either an early extubation group (n = 60; 15 / tg -  kg -x 
fentanyl and 2 to 6 mg. kg -1. hour -1 propofol and isoflurane) orto a conventional 
extubation group (n = 60; 50/xg.  kg -1 fentanyl and 0.1 mg • kg -1 midazolam and 
isoflurane). Cardiac morbidity (postoperative myocardial ischemia, postoperative 
myocardial infarction, and perioperative sympathoadrenal stress response), respi- 
ratory morbidity (postextubation apnca, alveolar-arterial oxygen gradient, pulmo- 
nary shunting, oxygen consumption, atelectasis, and reintubation), hemodynamic 
values and vasoactive medication requirements, intraoperative awareness, postop- 
erative cognitive function, 30 day mortality, and intensive care unit and hospital 
lengths of stay were compared between the two groups. Results: Fifty-one of the 
60 patients in each group (85%) were extubated within the defined time period. 
Postoperative extubation time and intensive care unit and hospital engths of 
stay were significantly shorter in the early group. At 48 hours after operation, 
there were no significant differences between the two groups in myocardial 
isehemia incidences, ischemia burdens, or creatine kinase isoenzyme MB 
levels. Four patients in the conventional group, but not in the early group, had 
postoperative myocardial infarction. The extubation anesthetics used were 
effective in suppressing the perioperative plasma catecholamine stress re- 
sponse in both groups. Postextubation apnea characteristics were similar 
between the groups. Intrapulmonary shunt fraction improved significantly in 
the early group at 4 hours after extubation. The incidences and degree of 
atelectasis did not differ significantly between the two groups. The incidences 
of treated postoperative complications were comparable between the two 
groups, but three patients in the conventional group died as  result of stroke 
or postoperative myocardial infarction. Conclusion: Early extubation after 
coronary artery bypass grafting is safe and does not increase perioperative 
morbidity. There is an improvement in postextubation i trapulmonary shunt 
fraction and a reduction in intensive care unit and hospital engths of stay. 
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T he North American population is rapidly increas- ing in percentage of older persons, and the 
utilization of coronary artery bypass grafting 
(CABG) in the elderly population is doubling every 
5 years)  The cost of morbidity and mortality after 
cardiac operations is inflated by increased severity 
of disease in patients undergoing CABG; these 
patients often are elderly, are undergoing extensive 
medical therapy, or have had previous angioplasty 
or revascularization. 2' 3 To diminish the escalating 
cost of cardiac operations, early postoperative tra- 
cheal extubation and discharge from the intensive 
care unit ( ICU) have been advocated. To date, 
however, there have been insufficient data to ensure 
that morbidity outcome and quality of care for these 
patients are not compromised by early extubation. It 
should be noted that the economic consequences 
associated with post -CABG complications are far 
more costly than those of uncomplicated recovery. 4 
This prospective, randomized, controlled clinical 
trial was designed to evaluate the safety of a modi- 
fied anesthetic protocol to provide shorter sedation 
and early extubation (1 to 6 hours) in patients after 
CABG, compared with that of the conventional 
anesthetic protocol for prolonged sedation and ex- 
tubation (12 to 22 hours). Cardiac morbidity and 
perioperative sympathoadrenal stress response, re- 
spiratory morbidity, intraoperative awareness, post- 
operative cognitive function, and recovery were 
compared between the two groups. 
Methods 
Patient population. With the approval of the institu- 
tional Ethics Committee, 120 patients undergoing elective 
CABG were included in and consented to the study. 
Patients considered as study candidates were younger 
than 75 years, were scheduled for morning operation, 
were of either sex, had left ventricular function grades I
through IV, and had either stable or unstable angina. 
Preoperative xclusion criteria were previous CABG or 
valvular heart operation, history of allergy to propofol or 
its constituents, left bundle branch block or current digi- 
talis therapy, documented myocardial infarction (MI) 
within previous 3 weeks, active congestive cardiac failure, 
inotropic therapy within 24 hours before study onset or 
current intraaortic balloon pump support, severe hepatic 
disease (alanine aminotransferase or aspartate amino- 
transferase >150 IU/L), renal insufficiency (creatinine 
>180/zmol/L), severe chronic obstructive pulmonary dis- 
ease (forced expiratory volume in 1 second <0.8 L), and 
history of seizure or stroke. 
Study groups. Patients were randomly and consecu- 
tively allocated according to a computer-generated ran- 
domization code to early (study) or conventional (control) 
groups. Demographic data were recorded. Preoperative 
sedation consisted of 1 to 3 mg sublingual lorazepam 11/2 
hours before the operation. 
Early extubation group. Anesthesia induction consisted 
of 15/xg • kg -1 intravenous fentanyl ---50 mg intravenous 
thiopental and 0.15 mg• kg -1 intravenous pancuronium 
for tracheal intubation. Anesthesia was maintained with 
0.2% to 1.5% isoflurane and oxygen before cardiopulmo- 
nary bypass (CPB). No benzodiazepine was used. After 
initiation of CPB, propofol infusion at 2 to 6 
rag. kg a • hour -~ was commenced and maintained until 
1 to 4 hours in the ICU. Postoperative sedation with 
propofol was adjusted to achieve aRamsay sedation score 
of 3 to 4. 5 Shivering was treated with 25 to 50 mg 
intravenous meperidine (Demerol). Persistent systemic 
hypertension (systemic blood pressure > 140 mm Hg) was 
treated with infusion of nitroglycerin, nitroprusside, or 
both, adjusted to achieve a systolic arterial pressure of 90 
to 130 mm Hg. An intravenous bolus of 20 mg esmolol or 
1 mg propranolol was used to control tachycardia (heart 
rate > 110 beats/min). A 50 to 100 mg indomethacin 
suppository was given for pain control at arrival in the 
ICU. Patients were assessed for tracheal extubation within 
1 to 6 hours (Appendix 1). Analgesia was maintained after 
extubation by a 1 to 4 mg• hour -~ intravenous injection 
of morphine. 
Conventional extubation group. Anesthesia induction 
consisted of 50 /xg • kg -~ intravenous fentanyl and 0.15 
mg • kg 1 intravenous pancuronium for tracheal intuba- 
tion. A 0.1 mg• kg -1 intravenous injection of midazolam 
was administered in the prebypass period. Isoflurane 
(0.2% to 1.5%) was used as required uring the peri-CPB 
period. In the ICU, routine infusions of morphine 12 to 10 
mg• hour -1) and midazolam (1 to 3 rag. hour- ) were 
adjusted to achieve the same Ramsay sedation score. 
Treatments for shivering, hemodynamic parameters, and 
cardiac rhythm control were the same as in the early 
group. Sedation was discontinued the next morning, and a 
50 to 100 mg indomethacin suppository was given for pain 
control. Patients were assessed for extubation at 7 AM, as 
in current conventional management. 
Surgical procedure. All patients had radial and pulmo- 
nary arterial pressures monitored. Standard CABG was 
performed. Patients underwent a median sternotomy, 
with harvesting of saphenous veins and internal thoracic 
arteries as conduits. Myocardial protection was achieved 
with intermittent antegrade cold blood cardioplegic infu- 
sion through the aortic root, and the systemic temperature 
was allowed to drift down to 33 ° C during CPB. Hemato- 
crit was maintained between 20% and 25% and CPB flow 
was maintained between 2.0 and 2.5 L. rain -a • m -2. The 
mean perfusion pressure was kept at 50 to 60 mm Hg by 
adjustment of nitroprusside or phenylephrine infusion. 
Patients were actively rewarmed to 38 ° C before removal 
of the aortic crossclamp and weaning from CPB. 
Outcome measurements 
Cardiac morbidity 
MYOCARDIAL mCHEMrA. A clinically validated iagnostic 
electrocardiographic monitor (Mortara Instrument, Mil- 
waukee, Wis.) for continuous real-time ST-segment anal- 
ysis in 12 leads was used .  6 The device, which compared 
samples to a baseline ST segment every 20 seconds, was 
attached to the patient 2 hours before operation. The 
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electrocardiogram was continuously monitored for 48 
hours after operation. The incidence and severity of 
myocardial ischemia before and after extubation were 
compared within each group and between groups at each 
time interval. Myocardial ischemia burden was calculated 
from the area under the curve for the level and duration 
of ST-segment depression. 
MI. Perioperative MI was diagnosed if either or both of 
the following findings were present: creatine kinase isoen- 
zyme MB (CK-MB) concentration greater than 50 IU/L 
and representing more than 8% of total creatine kinase 
(CK) or major 12-lead electrocardiographic changes from 
baseline in two or more leads. Major 12-lead electrocar- 
diographic hanges were new Q waves of at least 0.04 
seconds in duration and 1 mm in depth, ST-segment 
elevation or depression of greater than 2 mm lasting 48 
hours, and a symmetric T-wave inversion persisting for 48 
hours.7, 8Blood was analyzed for cardiac enzymes at 6, 12, 
24, 36, and 48 hours after the release of the aortic 
crossclamp. Postoperative lectrocardiogram was done 
daily for 3 days. 
Catecholamine stress response. Plasma catecholamine 
levels (norepinephrine, pinephrine, and cortisol) were 
determined at baseline, 1 minute after intubation and 
sternotomy, 30 minutes after initiation of CPB, 15 minutes 
after arrival in the ICU, and 1 hour after extubation. 
Levels were assayed by high-pressure liquid chromatogra- 
phy. 
Hemodynamic measurements. Heart rate, blood pres- 
sure, pulmonary artery pressure, central venous pressure, 
pulmonary capillary wedge pressure, cardiac index, car- 
diac output, systemic vascular esistance, and pulmonary 
vascular esistance were monitored and calculated at the 
following points: after induction, after intubation, after 
sternotomy, before CPB, after CPB, and hourly until 4 
hours after extubation. Perioperative medications used 
were compared between the two groups. 
Ventilatory morbidity 
APNEA AND RESPIRATORY PATTERN. Respiratory induc- 
tive plethysmography is clinically validated and has proved 
reliable in critically ill patients. 9 The Respitrace (Non- 
Invasive Monitoring Systems [NIMS], Miami Beach, Fla.) 
was recalibrated before extubation. After extubation, pa- 
tients were continuously monitored for 4 hours. Breath- 
by-breath measurements of the following variables were 
recorded: respiratory frequency, inspiratory and expira- 
tory times, tidal volume, inspiratory flow rate, minute 
ventilation, and percentage of rib cage or abdominal 
contributions to tidal volume. Central apnea was defined 
as an expiratory pause longer than 10 seconds or a tidal 
volume less than 100 ml. Obstructive apnea was defined as 
an expiratory pause longer than 10 seconds, negligible 
tidal volume associated with out-of-phase chest wall and 
abdominal movements, and a labored breathing index 
greater than 1.6. Ventilatory data were compared between 
the two groups. 
ARTERIAL BLOOD GAS VALUES. Arterial blood gas values 
were measured at 5 minutes and 1, 2, and 4 hours after 
extubation. 
ALVEOLAR-ARTERIAL OXYGEN GRADIENT. Alveolar-arte- 
rial oxygen gradient (A-aDo2) was derived at 5 minutes 
after intubation and at 30 minutes and 4 hours after 
extubation from the standard formula: A-aDo 2 = PAO a -- 
Paoz, where PAO2 is alveolar oxygen tension and Pao2 is 
arterial oxygen tension. 
INTRAPULMONARY SHUNT AND OXYGEN CONSUMPTION. 
Both intrapulmonary shunt (Qs/Qt) and oxygen consump- 
tion (Voa) were calculated at 5 minutes after intubation 
and at 30 minutes and 4 hours after extubation from the 
standard formulas: Qs/Qt = (Cco 2 - Cao2)/(Cco 2 - 
CVo2) and 9-o2 = CO(Cao2 - 09o2), where Cco2 is 
pulmonary capillary oxygen concentration, Cao2 is arterial 
oxygen concentration, C~,o2 is mixed venous oxygen con- 
centration, and CO is cardiac output. 
ATELECTASIS. Preoperative and postoperative chest 
roentgenograms were graded at 24, 48, and 72 hours after 
operation by a radiologist who was blinded to study group 
assignment, a° 
Awareness and cognitive function. Intraoperative aware- 
ness during the two anesthetic techniques was assessed by 
a standard questionnaire at 4 and 24 hours after extuba- 
tion. The Mini-Mental State test was used to compare 
cognitive function before operation and 4 and 48 hours 
after extubation. This screening test combines a high 
validity and reliability with brevity and ease of application, 
avoiding fatigue in elderly subjects, zl
Other postoperative complications. Postoperative blood 
loss, shivering, reintubation, respiratory or cardiac arrest, 
and cerebrovascular ccidents were recorded. Cerebro- 
vascular accident was defined as the sudden onset of focal 
neurologic deficit, symptoms of focal neurologic deficit 
persisting longer than 24 hours, or both, as documented by 
a neurologist. 
Mortality. Mortality was defined as any death occurring 
within 30 days after operation or during hospital stay. 
Discharge criteria and actual discharge times. The dis- 
charge criteria were used to determine the time when the 
patient was medically fit to be discharged from either the 
ICU or hospital (Appendix 2). The actual discharge time 
was when the patient was actually discharged from either 
the ICU or hospital. The discharge criteria time provided 
a more valid and consistent comparison for postoperative 
recovery between the two groups than did the actual 
discharge time. Even though some patients were medi- 
cally fit to be discharged from the ICU to the step-down 
unit on the same day, in practice they were not transferred 
out until the morning after the operation. Similarly, the 
actual discharge time from hospital was often longer than 
the time determined by discharge criteria because of 
social or home placement reasons. 
Data collection and statistical analysis. Data for each 
patient were collected by a research nurse during the 
surgical course from hospital admission to discharge. 
Patients who did not fulfill the extubation criteria at the 
timed period were considered to have failure of extuba- 
tion criteria. The reason for the failure was documented, 
and these patients were not excluded from statistical 
analysis. Because of failure of extubation, Respitrace data 
could not be collected. Myocardial ischemia and infarc- 
tion data were collected and were included in the group 
comparisons. 
The Clinical Trials Unit in the Center for Cardiovascu- 
lar Research at The Toronto Hospital performed the 
biostatistical nalysis. The distribution of each variable 
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Table I. Demographic data 
Early Conventional 
(n =60) (n = 60) 
Age (yr) 59.3 --- 8.8 61.2 ± 8.7 
Weight (kg) 79.5 -- 14.4 78.7 _+ 13.7 
Left ventricular grade (no.) 1.8 ± 0.9 1.8 _+ 0.8 
I 27 24 
II 22 23 
III 7 11 
IV 4 2 
No. of grafts per patients 3.7 -+ 0.9 3.7 ± 0.9 
CPB duration (min) 84.8 -+ 28.3 86.8 ± 25.5 
Crossclamp duration (min) 62.1 -+ 19 64.1 ± 19.5 
Table II. Postoperative r covery 
Early Conventional 
(n = 51) (n = 51) 
Extubation time (hr) 4.1 _+ 1.1" 18.9 + 1.4 
ICU discharge criteria 17.3 _+ 12.1" 25.6 + 12.3 
met (hr) 
Actual ICU discharge (hr) 29.2 _+ 11.7 30.9 ± 12.8 
Hospital discharge criteria 5.7 _+ 2.4* 6.6 _+ 2.4 
met (days) 
Actual hospital discharge 7.0 _+ 2.5* 8.2 ± 3.5 
(days) 
*p < 0.02 
was examined, and significant variables were used for the 
outcome measurements. Discriminant function analysis was 
performed to ascertain whether a classification scheme de- 
veloped and what variables contributed to group separation. 
Between-group comparisons of parametric data were as- 
sessed with unpaired t tests. A two-sided Fisher's Exact Test 
was used to analyze dichotomous frequency data. Serial 
comparisons of parametric data were analyzed by either a 
one-way analysis of variance or a two-way between-group 
analysis of variance with repeated measurements over time, 
followed by post hoc Scheffe's tests. All results were ex- 
pressed as mean (_+ standard eviation). 
Results 
There were no differences in demographic data, 
including the distribution of left ventricular function, 
between the early and conventional groups (Table I). 
Fifty-one of 60 patients in the early group (85%) were 
extubated within the defined 6 hours after operation, 
and 51 of 60 patients in the conventional group (85%) 
were extubated within the defined 22 hours after 
operation. The postoperative xtubation time and 
ICU and hospital engths of stay were significantly 
shortened in the early group (Table II). There were 
nine patients (15%) in each group who did not meet 
Table III. Extubation criteria failure 
Early Conventional 
(n :9 )  (n =9) 
Resternotomy (bleeding) 1 2 
IABP or LCO syndrome 5 4 
Inadequate ABGs 2 1 
Reintubation (pneumonia) 1 0 
CVA and death 0 2 
btBP, lntraaortic balloon pump; LCO, low cardiac output; ABG, arterial 
blood gas values; CVA, cerebrovascular accident. 
the extubation criteria within the defined time period, 
with comparable causes for failure (Table III). 
Cardiae morbidity. No significant difference was 
found in postoperative myocardial ischemia inci- 
dence and ischemia burden between the two groups 
(Fig. 1). At arrival to the ICU, the incidence of 
myocardial ischemia was comparable between the 
early (35%) and conventional (31.7%) groups, de- 
creasing in both to 16.7% after 4 hours. In the first 
24 hours after operation, the ischemia incidence 
ranged from 13.3% to 20% in the early group and 
5% to 16.7% in the conventional group; it progres- 
sively improved at end of 48 hours after operation to 
6.7% in the early group and to 3.3% in the conven- 
tional group. In the first 24 hours after operation, 
myocardial ischemia burden appeared to be higher 
in the conventional group; on the second day after 
operation, however, myocardial ischemia burden 
tended to be higher in the early group. The mean 
duration of myocardial ischemia was 156.6 + 143.2 
minutes in the early group and 107.9 + 119.5 rain in 
the conventional group. 
No significant difference was found between the 
two groups in CK-MB levels (Fig. 2), but total CK 
levels at 24 and 36 hours after operation were 
significantly higher in the conventional group. Four 
patients in the conventional group had postopera- 
tive MIs, and two of them died as a result of a 
difficult surgical graft. No postoperative MIs oc- 
curred in the early group. 
Hemodynamic values and cateeholamine stress 
response. Plasma catecholamine (norepinephrine, 
epinephrine, and cortisol) levels were all within the 
normal clinical range and did not differ significantly 
between the two groups (Fig. 3). There were no 
significant differences in perioperative hemody- 
namic values (heart rate, blood pressure, pulmonary 
artery pressure, central venous pressure, pulmonary 
capillary wedge pressure, cardiac index, cardiac out- 
put, systemic vascular resistance, and pulmonary 
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Fig. L Comparison of incidences of postoperative myocardial ischemia between early and conventional 
(Cony) groups through 48hours. 
vascular resistance) or in vasoactive medication 
requirements between the two groups. 
Ventilatory morbidity. Postextubation oxygen 
saturation, respiratory rate, labored breath index 
(thoracoabdominal coordination), and apnea char- 
acteristics (Table IV) were similar between the two 
groups. Tidal volume (Fig. 4) and central respiratory 
drive improved with time in both groups. The early 
group had consistently ower minute ventilation and 
predominantly abdominal breathing after extuba- 
tion. The incidence and degree of pulmonary atel- 
ectasis did not differ significantly between the two 
groups at 72 hours after operation. 
There was no evidence of postextubation respira- 
tory acidosis or hypoxemia in the early group when 
compared with the conventional group (inspired 
oxygen fraction 0.3). Qs/Qt was found to be signifi- 
cantly improved in the early versus conventional 
group at 4 hours after extubation (Table V). 
Awareness and cognitive function. One patient in 
the early group reported awareness but no pain after 
CPB. One patient in the conventional group also 
reported awareness after operation, during trans- 
portation to the ICU. Although the difference was 
not statistically significant, the early group per- 
formed better and returned to baseline l vel earlier 
on the Mini-Mental State test than did the conven- 
tional group. 
Postoperative complications. The incidences of 
postoperative treated complications were compara- 
ble between the two groups, as shown in Table VI. 
The conventional group had twice the incidence of 
postoperative shivering (16.7%) seen in the early 
group (8.3%). Deaths occurred only in the conven- 
tional group; these three patients died of cerebro- 
vascular accident and postoperative MI. The post- 
operative bleeding from chest tube drainage at 24 
hours in the early group (548.2 _+ 218.3 ml) was 
comparable to that in the conventional group 
(574.9 _+ 255.3 ml). 
Discussion 
Although routine use of prolonged controlled 
ventilation in cardiac surgical patients has been 
standard practice for the past three decades, early 
tracheal extubation of these patients is not a new 
idea j2, 23 Cost containment and efficient resource 
use force the pendulum back to the debate of early 
extubation for cardiac surgical patients. Several 
groups have recently advocated early postoperative 
tracheal extubation and management of patients 
undergoing CABG in a cardiac recovery or step- 
down unitJ 4-16 Early extubation is now feasible 
because of improvement in anesthesia management 
coupled with advancements in surgical technique, 
myocardial protection, and postoperative hemosta- 
sis. The concept of balanced anesthesia r ther than 
high-dose narcotics for cardiac operations has been 
reestablishedJ 7'18 Also, inhalational anesthetics 
such as isoflurane have been confirmed not to cause 
clinically significant coronary steal. 19'2° Specific 
postoperative s dation medications such as propofol 
are able to provide shorter postoperative s dation 
and time to extubation, with lower incidence of 
lUlL 
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Fig. 2. Comparison of postoperative CK-MB enzyme l vels between the early and conventional (Cony) 
groups through 48 hours. 
hypertension.21, 2 Morbidity and cost issues of early 
and late extubation for CABG have been raised and 
are still being debated. 23' 24 
Cardiac morbidity. Perioperative myocardial 
ischemia has been shown to be associated with 
postoperative MI in patients undergoing cardiac 
operations. 25 Despite apparently successful revascu- 
larization, patients undergoing cardiac operations 
have had postoperative ischemia documented by 
continuous electrocardiography. 26 The peak inci- 
dence of ischemia (42% to 45%) was found within 2 
hours after CPB and progressively reduced to less 
than 10% by 18 hours after CPB. Although intensive 
analgesia did not reduce postoperative MI rate, 
Mangano and coworkers 26 suggested that it is essen- 
tial to reduce postoperative myocardial ischemia 
after CABG. The problem is that these patients 
would need to remain intubated and ventilated for 
12 to 24 hours after the operation. The merit of our 
study is that it is the first prospective, randomized, 
comparative study of the effects of early versus 
conventional extubation on myocardial ischemia 
and MI. The incidences of myocardial ischemia were 
comparable in the early group (35%) and the con- 
ventional (31.7%) group, with both decreasing to 
16.7% after 4 hours. In the first 24 hours after 
operation, the ischemia incidences ranged from 
13.3% to 20% in the early group and from 5% to 
16.7% in the conventional group; these progres- 
sively improved to 6.7% in the early group and 3.3% 
in the conventional group at 48 hours after opera- 
tion. Myocardial ischemia burden appeared to be 
higher in the conventional group during the first 24 
hours after operation; on the second day after 
operation, however, it tended to be higher in the 
early group. We demonstrated no significant differ- 
ences in postoperative myocardial ischemia inci- 
dence and ischemia burden between the two 
groups. 
No significant differences in CK-MB levels were 
found between the two groups, but total CK levels 
were significantly higher in the conventional group 
at 24 and 36 hours after operation. Four patients in 
the conventional group had postoperative MIs, 
whereas no postoperative MIs occurred in the early 
group. Although the sample size in this study does 
not allow us to prove a significant reduction of 
postoperative MI with early extubation, the study 
does provide vidence that early extubation does not 
increase the risk of postoperative MI compared with 
conventional extubation. 
Despite successful revascularization in patients hav- 
ing CABG, there is also a decrease in left ventricular 
ejection fraction compared with preoperative alues. 27 
It has been argued that a patient extubated in the first 
few hours after CPB might "look good" but have both 
functional and metabolic ompromise of the myocar- 
diumY' 2s Our data, with comparable demographic 
values including distribution of poor left ventricular 
function, indicate that early extubation anesthetic 
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management provides stable p rioperative hemody- 
namic values without an increase in vasoactive medi- 
cation requirement with respect to conventional man- 
agement. 
Sympathoadrenal stress. Cardiac operations 
present a specific problem because of the effects of 
hypothermic hemodilutional CPB on the activation 
of the sympathetic nervous system. 29 Epinephrine 
levels have been found to remain markedly e evated 
(300%) for 3 hours after arrival in the ICU. This 
suggests hat the stress of CPB does not end with the 
operation. In an event comparison, ur data dem- 
onstrate that the early extubation anesthetic proto- 
col adequately suppressed the perioperative surgical 
and extubation stress response. 
Respiratory morbidity. Prophylactic ventilation 
was championed in the early days of cardiac surgery 
to reduce the work of breathing with greater post- 
operative analgesia nd promote better gas ex- 
change. 3° More recent studies, however, do not 
support he use of prophylactic ventilation to pre- 
vent atelectasis. Dantzker and coworkers 31found no 
difference in Qs/Qt whether the patient was intu- 
bated or breathing spontaneously after CABG. A 
retrospective analysis of cardiac surgical patients 
revealed a higher incidence of postoperative atelec- 
tasis and longer ICU stays among patients in whom 
extubation was delayed beyond 24 hours. 32 Quasha 
and colleagues 13reported an 89% success rate for 
early extubation and a lower incidence of lobar 
collapse in 18 patients undergoing CABG; they 
attributed these results to an improved ability to 
Table IV. Postextubation apnea 
Ear ly  Conventional 
Incidence 27.5% (14/51) 33.3% (17/51) 
Duration (sec) 17.7 +- 23.0 15.7 _+ 28.6 
Index (rate/hr) 
1 hr 13 15 
2 hr 4 8 
3 hr 2 9 
4 hr 2 8 
cough. Although some studies 13-16 indicate that 
early extubation is possible or feasible in CABG, the 
incidence and outcome of respiratory complications 
(such as reintubation for respiratory failure, apnea, 
acidosis, and hypoxemia) after early extubation are 
not well documented. Prakash, Meij, and Van Der 
Borden 33 noted that the transition from controlled 
ventilation to either spontaneous or intermittent 
mandatory ventilation was associated with an in- 
crease in oxygen consumption and carbon dioxide 
production in patients undergoing CABG. Further- 
more, Tulla nd coworkers 34 suggested that return 
to spontaneous ventilation after cardiac operations 
was associated with increased work of breathing and 
risk of arterial hypoxia. 
In our study, postoperative analgesia was pro- 
vided by an indomethacin suppository before extu- 
bation. Unlike potent narcotics, this nonsteroidal 
anti-inflammatory drug has no respiratory depres- 
sive effect. Our data demonstrate hat the respira- 
tory mechanics after extubation were comparable 
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Fig. 4. Comparison of postextubation tidal volumes between the early and conventional (Cony) groups 
through 4hours. 
Table V. Postextubation arterial blood gas values 
Baseline 30 min 90 min 240 min 
Early Conventional Early Conventional Early Conventional Early Conventional 
pH 7.41 -+ 0.03 7.41 --+ 0.03 7.36 -+ 0.03 7.39 + 0.03 7.37 -+ 0.03 7.39 -+ 0.04 7.37 -+ 0.03 7.39 -+ 0.03 
Paco 2 39.6 -+ 4.2 38.9 + 4.5 40.8 -+ 4.8 39.3 -+ 3.4 39.7 -+ 4.5 39.5 -+ 3.9 39.6 -4- 4.3 39.6 -+ 3.6 
Paoz 140.9 _+ 89.0 131.3 --- 73.4 142.5 -+ 43.6* 125.2 _+ 37.4 138.6 + 37.4 125.7 _+ 35.5 145.2 _+ 48.8 129.9 _+ 51.8 
Vo 140.8 _+ 50.9 139.6 -- 48.1 227.5 -+ 74.9 214.1 _+ 68.4 - -  - -  241.5 _+ 115.6 206.6 + 82.5 
Qs/Qt 22.6 _+ 10.6 20.3 -+ 9.8 16.4 -+ 13.6 21.5 _+ 17.4 - -  - -  13.3 + 9.2t 25.1 _+ 24.1 
Paco 2, Arterial carbon dioxide tension; Po2, arterial oxygen tension. 
*p < 0.035 between groups. 
tp < 0.002 between groups. 
between the two groups once the extubation criteria 
had been fulfilled. It did not matter whether the 
patients were extubated within a few hours or the 
next day after operation. The first hour after extu- 
bation is most crucial in respiratory care, as re- 
flected by the apnea index. The tidal volume and 
central respiratory drive also improved progressively 
during the first hour after extubation. None of the 
early extubations resulted in respiratory acidosis, 
hypoxemia, or increase in postoperative pulmonary 
atelectasis. Early extubation improved Qs/Qt. 
Postoperative r covery. There were nine patients 
in each group who could not be extubated in the 
prescribed time interval. The main reason was low 
cardiac output syndrome. In the early group, it was 
the result of temporary need of inotropic or in- 
traaortic balloon pump support, whereas in the 
conventional group, it was the result of periopera- 
tive MI. As indicated in Tables III and VI, major 
postoperative complications occurred mainly in the 
conventional group. 
Clinically, the early group performed better and 
returned to baseline level earlier in the Mini-Mental 
test than did the conventional group. This allowed 
earlier chest tube removal, mobilization, and oral 
intake of food. The early group thus met discharge 
criteria for the ICU (17.3 hours vs 25.6 hours) and 
the hospital (5.7 days vs 6.6 days) much earlier than 
did the conventional group. In comparison, ICU 
length of stay averages from 2.3 to 5.2 days and 
hospital length of stay averages 13.9 days after 
CABG, as detailed in a multicenter study in Canada 
reported in 1993. 35 
Conclusion 
In this prospective, randomized, controlled clini- 
cal trial, our results indicate that early tracheal 
extubation of patients after CABG does not in- 
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Table VI. Treated complications in the ICU 
Early Conventional 
(n = 60) (n = 60) 
Seizure and stroke 0 2 
Low cardiac output syndrome 7 8 
Myocardial infarction 0 4 
Arrhythmia 5 4 
Reintubation 1 0 
Bleeding 1 2 
Low urine output 2 1 
Shivering 5 10 
Death 0 3 
crease perioperative cardiac, respiratory, hemody- 
namic, or sympathoadrenal  morbidity. It improves 
postextubation Qs/Qt and postoperative recovery, 
resulting in reduced lengths of stay in the ICU and 
the hospital. 
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Appendixes 
Appendix 1 
Tracheal extubation criteria 
• Patient responsive and cooperative 
• Negative inspiratory force >-20  cm H~O 
• Vital capacity >10 ml • kg -1 
• Arterial oxygen tension >80 mm Hg, inspired oxygen 
fraction -<0.5 
• Cardiac index >2.0 L. min -1 • m 2 
• Oropharyngeal temperature >36.5 ° C 
• pH >7.30 
• Chest tube drainage <100 ml/hour×2 hours 
• Absence of uncontrolled arrhythmia 
Appendix 2
ICU discharge criteria 
• Alert and cooperative patient 
• No inotropic support and no significant arrhythmia 
• Adequate ventilation (arterial oxygen tension >80 
mm Hg, arterial carbon dioxide tension <60 mm Hg, 
arterial oxygen saturation >90%, inspired oxygen 
fraction -<0.5 by face mask) 
• Chest tube drainage <50 ml/hour×2 hours 
• Urine output >0.5 ml. kg -1 • hour -~ 
• No active seizure 
Hospital discharge criteria 
• Hernodynamically stable 
• Stable cardiac rhythm 
• Noninfected incisions and afebrile patient 
• Ability to void, bowel movements 
• Independent ambulation and feeding 
CARDIOPULMONARY BYPASS, MYOCARDIAL 
MANAGEMENT, AND SUPPORT TECHNIQUES 
PROTECTIVE EFFECTS OF DIMETHYL AMILORIDE AGAINST POSTISCHEMIC MYOCARDIAL 
DYSFUNCTION IN RABBIT HEARTS: PHOSPHORUS 31-NUCLEAR MAGNETIC RESONANCE 
MEASUREMENTS OF INTRACELLULAR PH AND CELLULAR ENERGY 
Akira Koike, MD a 
Toshiaki Akita, MD a 
Yoshihiro Hotta, PhD b 
Kazumi Takeya, PhD b 
Itsuo Kodama, MD c 
Mitsuya Murase, MD a 
Toshio Abe, MD a 
Junji Toyama, MD c 
The effects of 5-(N,N-dimethyl)amiloride, a potent and specific Na+-H + 
exchange inhibitor, were investigated in isolated perfused rabbit hearts sub- 
jected to ischemia and reperfusion. Phosphorus 31-nuclear magnetic reso- 
nance spectroscopy was used to monitor intracellular pH, creatine phosphate, 
/]-adenosine triphosphate, and inorganic phosphate. After cardioplegic arrest 
with St. Thomas' Hospital solution, normothermic (37 ° C) global ischemia was 
induced for 45 minutes, and the hearts were reperfused for 50 minutes. 
Dimethyl amiloride at 10/xmol/L, which has minimal inotropic and chrono- 
tropic effects on the nonischemic heart, was added to the cardioplegic solution. 
Treatment with dimethyl amiloride reduced the elevation of left ventricular 
end-diastolic pressure during and after the ischemia and improved the 
postischemic recovery of developed pressure from 76% -+ 3.2% at 30 minutes 
of reperfusion i  control hearts (n = 6) up to 99% + 1.9% in hearts treated 
with dimethyl amiloride (n -- 8). Dimethyl amiloride did not affect he decline 
in intracellular pH during ischemia for up to 30 minutes but enhanced the 
intracellular acidosis thereafter. The intracellniar pH at the end of ischemia 
was 6.21 - 0.05 in control hearts compared with 5.24 - 0.17 in hearts treated 
with dimethyl amiloride (p < 0.05). During reperfusion, intracellular pH of 
hearts treated with dimethyl amiloride was less than control for 5 minutes, but 
subsequent recovery of intracellular pH was similar to control. Treatment with 
dimethyl amiloride did not affect creatine phosphate breakdown, inorganic 
phosphate accumulation, and l~-adenosine triphosphate depletion during 45 
minutes of ischemia. The creatine phosphate resynthesis and inorganic 
phosphate reduction during reperfusion were also unaffected. These findings 
suggest hat Na+-H + exchange plays an important role not only during 
reperfusion but also during ischemia for the development of postischemic 
cardiac dysfunction most likely by inducing primary Na + and secondary Ca 2+ 
overload. Specific Na+IH + exchange inhibitors like dimethyl amiloride would 
have a potential therapeutic profile in cardiac surgery, especially if added 
before ischemia. (J Thorac Cardiovasc Surg 1996;112:765-75) 
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p harmacologic evidence for the involvement of 
sarcolemmal Na+-H + exchange in myocardial 
ischemia-reperfusion njury has emerged from many 
experimental studies showing various salutary ef- 
fects of Na+-H + exchange inhibitors, including 
amiloride and other organic compounds. 1-3 In ani- 
mal experiments in which rats, guinea pigs, rabbits, 
and dogs were used, many investigators have dem- 
Copyright © 1996 by Mosby-Year Book, Inc. 
0022-5223/96 $5.00 + 0 12/1/73914 
765 
7 6 6 Koike et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1996 
onstrated that treatment of hearts with amiloride or 
other compounds having more specific inhibitory 
action against Na+-H + exchange improves po tisch- 
emic contractile recovery, 4-7 reduces reperfusion 
arrhythmias, s diminishes creatine kinase effiux dur- 
ing reperfusion, 6 preserves microscopic ellular in- 
tegrity, 9 or reduces Na +~ and Ca 2+i accumula- 
tion.4, 10 Regarding the precise nature of their 
beneficial effects, however, several issues remain to 
be resolved. 
Controversy exists as to whether cardiac protec- 
tion by Na+-H ÷ exchange inhibitors is limited to 
reperfusion or would also occur under ischemic 
conditions. 2'3 Na÷-H + exchange inhibitors were 
shown to have a certain protective effect if the 
compound was given only during reperfusion. 6-9 
Nevertheless, protection is also present during isch- 
emia 9,11,12 and is even more pronounced if the 
inhibitor is given during ischemia nd reperfusion. 9 
The protective ffects of Na+-H + exchange inhibi- 
tors were associated with the preservation of high- 
energy phosphates in some studies, 9'13 but not in 
others.4, 10 
The cardioprotective effects of Na +-H + exchange 
inhibitors have the potential to be clinically useful. 
In view of the preclinical data, the most promising 
indications for the inhibitors include the typical 
ischemia-reperfusion situation, in which the start of 
ischemia and reperfusion is known and sufficient 
concentrations of the compound can be applied to 
the heart. This is the case in cardiac surgery. 3 
During cardiac operations, the contraction of the 
heart has to be stopped by a cardioplegic solution. 
The heart is disconnected from systemic blood flow 
and is reperfused at the end of the procedure. 
Various protective drugs are, therefore, usually ap- 
plied to the cardioplegic solution so that their 
concentration i the heart will remain high enough 
without affecting other organs. To our knowledge, 
however, little information is available as to the 
cardioprotective effects of Na+-H + exchange inhib- 
itors against ischemia-reperfusion injury when ap- 
plied to the cardioplegic solution. 
The current study was designed to gain further 
insight into the mechanism of cardioprotective ac- 
tion of Na+-H + exchange inhibitors and their po- 
tential therapeutic profile in cardiac surgery. We 
investigated the effects of 5-(N,N-dimethyl) amilo- 
ride (DMA), a more potent and more specific 
inhibitor of Na+-H + exchange than amiloride, &14 
on the sequential changes of left ventricular contrac- 
tility, intracellular pH (pHi), and high-energy phos- 
phates in isolated perfused rabbit hearts subjected 
to normothermic global ischemia during cardiople- 
gic arrest and subsequent reperfusion. DMA was 
applied to the cardioplegic solution, and pHi and 
energy metabolism were monitored by use of phos- 
phorus 31-nuclear magnetic resonance (NMR) 
spectroscopy. 
Materials and methods 
Preparation. Hearts were obtained from young white 
rabbits, 4 to 7 weeks old, weighing 500 to 800 gm. After 
intravenous administration of heparin (1000 IU) and 
thiamylal sodium (20 mg/kg), hearts were quickly excised 
and placed in cold (4 ° C) perfusion solution. The aorta 
was cannulated for nonrecirculating Langendorff perfu- 
sion at a constant hydrostatic pressure (75 cm H20). The 
control perfusate was a modified phosphate-flee Krebs- 
Henseleit bicarbonate buffer solution of the following 
composition (in millimoles per liter): NaC1, 118; KC1, 5.9; 
NaHCO3, 25; MgSO4, 1.2; CaC12, 2.5; and glucose, 5.5. 
The solution was equilibrated with 95% oxygen and 5% 
carbon dioxide to achieve a pH of 7.4 at 37 ° C. A latex 
balloon (size 4.3 mm in maximal diameter and 6.3 mm in 
length, Hirokawa, Niigata, Japan) was introduced into the 
left ventricle via the left atrium and connected to a 
strain-gauge transducer (MIP-5100, Baxter, Tokyo, Ja- 
pan) for measurement of isovolumic left ventricular pres- 
sure. The balloon was filled with distilled water containing 
a 0.5 mol/L concentration f methylene diphosphonic a id 
as external standard of the NMR spectral reference. The 
left ventricular end-diastolic pressure was adjusted to 5 
mm Hg during the equilibration period in each heart, and 
the volume was unchanged uring the experiments. The 
left ventricular developed pressure was calculated by 
subtracting left ventricular end-diastolic pressure from left 
ventricular systolic pressure. The maximum rate of con- 
traction and relaxation (+dp/dt) was obtained by elec- 
tronic differentiation. The pulmonary artery was incised to 
ensure adequate right ventricular venting. Myocardial 
temperature was maintained at 37 ° -+ 0.5 ° C by a water- 
jacketed perfusion line and a continuous tream of air 
around the sample tube of NMR. 
All animals have received humane care in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No. 86-23, revised 1985). 
NMR spectroscopy. In all the ischemia-reperfusion ex- 
periments, 31P-NMR spectra were monitored along with 
simultaneous recording of ventricular pressure. The heart 
connected tothe Langendorff perfusion line was placed in 
a standard 20 mm NMR tube with the apex approximately 
2.5 cm from the bottom of the tube, and the tube was 
inserted into the NMR coil. The effluent was removed 
from a level above the heart by a peristaltic pump, leaving 
the heart submerged in a fixed volume of the perfusate. 
31P-NMR spectra were obtained at 161.8 MHz on a 
GSX 400 spectrometer (Jeol Datum Co. Ltd., Tokyo, 
